Pcr method for super-amplification

ABSTRACT

The invention relates to a method for the duplication of nucleic acids by means of a polymerase chain reaction, in the case of which a cycle consisting of the steps of denaturing, annealing and elongation is repeatedly performed. In one embodiment, the yield (g) of specimens of a nucleic acid to be duplicated, at the end of at least one passage of the cycle, is less than 80 percent of the specimens of the nucleic acid present at the beginning of said passage and, in the case of at least one passage of the cycle, the reaction time (tA) is less than one second. In addition, in a further embodiment, the number (k) of passages of the cycle of the polymerase chain reaction is greater than 45 and/or in at least one of the passage the cycle time tc is less than 20 seconds.

FIELD OF THE INVENTION

The invention relates to a method for the amplification of nucleic acidsby means of a polymerase chain reaction (PCR).

BACKGROUND OF THE INVENTION

PCR methods are known from the prior art. The patent specification U.S.Pat. No. 4,683,202 B1 discloses a method, with which at least onespecific nucleic acid sequence contained in a nucleic acid or a mixtureof nucleic acids can be amplified, wherein each nucleic acid consists oftwo separate, complementary strands, of equal or unequal length. Themethod comprises: (a) treating the strands with two primers for eachdifferent specific sequence being amplified under such conditions that,for each different sequence being amplified, an extension product foreach primer is synthesized, which is complementary to the respectivenucleic acid strand. Said primers are selected so that they aresubstantially complementary to different strands of each specificsequence, so that the extension product that is synthesized from aprimer can be used, if separated from its complement, as a template forthe synthesis of the extension product of the other primer; (b)separating the primer extension products from the templates, on whichthey were synthesized so that single-stranded molecules are produced;(c) treating the single-stranded molecules from step (b) with theprimers from step (a) under such conditions that a primer extensionproduct is synthesized, wherein each of the single strands of step (b)is used as a template. The steps can be carried out one after the otheror simultaneously. In addition the steps (b) and (c) can be repeateduntil the desired degree of sequence amplification is achieved.

In the international application laid open for public inspection WO2007/143034 A1, methods are disclosed that are to be suitable forperforming a PCR method. The methods may include the use of an opticalradiation source for heating in a PCR method. The methods may alsoinclude the use of surface plasmon resonance or fluorescence resonanceenergy transfer for monitoring a PCR method in real-time. The methodsmay further include the immobilization of a template, primer or apolymerase on a surface such as gold or another surface that is activein relation to the surface plasmon resonance.

The patent application US 2002/0061588 A1 discloses methods for makingnucleic acids locally and directly responsive to an external signal. Thesignal acts only on one or a plurality of specific localized portions ofthe nucleic acid. According to the invention the signal can change theproperties of a specific nucleic acid and thereby also change itsfunction. Accordingly the invention provides methods for regulating thestructure and functioning of a nucleic acid in a biological samplewithout influencing other constituent parts of the sample. In oneembodiment a modulator transfers heat to a nucleic acid or a part of anucleic acid, which results e.g. in intermolecular or intramolecularbonds being destabilized, and the structure and stability of the nucleicacid changing. Preferred modulators include metal nanoparticles,semiconductor nanoparticles, magnetic nanoparticles, oxide nanoparticlesand chromophores. It is also proposed to use these methods inassociation with a PCR method. It is proposed in particular to control aPCR reaction with a modulator.

The patent application DE 10 2012 201 475 A1 relates to a method for theamplification of nucleic acids. In this method, electromagneticallyexcited nanoparticles in a reaction volume transfer heat to theirenvironment through excitation. If the heat input is below a criticalduration, which depends on the average particle distance in the solutionand thus the concentration of the nanoparticles, a very rapid denaturingcan be achieved, wherein the duration of the excitation of thenanoparticles is very much shorter than the cycle duration.

The patent DE 10 2013 215 166 B3 (publication date of the grant ofpatent: 30 Oct. 2014) of the inventors of this patent applicationcontains a method for super-amplification, wherein the shortening of thecycle duration leads to a low yield per cycle, but which is more thancompensated by the possibility of being able to perform more cycles pertime unit.

The patent application US 2003/0143604 A1 relates to the use ofnanoparticle detection probes for monitoring amplification reactions, inparticular PCR. The patent application deals primarily with the use ofnanoparticle-oligonucleotide conjugates which are treated with aprotective reagent such as bovine serum albumen, in order to detect atarget polynucleotide quantitatively and qualitatively. The patentapplication discloses a nucleic acid amplification and detection usinggold nanoparticle primers. In a first step the nucleic acid target isdenatured in the presence of the gold nanoparticles, to which primersare attached. In a second step the gold nanoparticles hybridize with theprimers attached thereto to the nucleic acid target and a copy of thecomplementary DNA sequence is produced based on the nucleic acid primerswhich are attached to the nanoparticles. The first and second steps arerepeated and the optical signal which is produced through the binding ofcomplementary nanoparticle probes that have been amplified is measured.

The patent specification EP 1 842 924 B1 discloses a method fordetermining an initial concentration of nucleic acids using nucleic acidreal-time amplification data, wherein a measured fluorescence, due tothe amplification, passes through a function dependent on the number ofcycles passed through.

Object of the Invention

It is the object of the invention to provide an improved method for theamplification of nucleic acids by means of a polymerase chain reaction(PCR). It is in particular the object to facilitate a more rapid and/orgreater amplification of nucleic acids by means of a PCR.

Solution According to the Invention

The object is achieved according to the invention by a method for theamplification of nucleic acids by means of a polymerase chain reaction(PCR), wherein a cycle consisting of the steps: denaturing, annealingand elongation is performed repeatedly.

The solution of the object is accomplished according to the inventionfurthermore by a method for the amplification of nucleic acids by meansof a PCR, wherein a cycle consisting of the steps: denaturing, annealingand elongation is performed repeatedly, wherein the yield (g) ofspecimens of a nucleic acid to be amplified at the end of at least oneof the passages of the cycle is less than 80% of the specimens of thenucleic acid present at the start of this passage of the cycle, and inat least one of the passages of the cycle a duration of effect (t_(A))is shorter than one second.

The object is accomplished furthermore by a method for the amplificationof nucleic acids by means of a PCR, wherein a cycle consisting of thesteps: denaturing, annealing and elongation is repeatedly passedthrough, wherein the number (k) of the passages of the cycle of thepolymerase chain reaction is greater than 45. In a PCR, a cycle thatpreferably includes, once in each case, the steps: denaturing, annealing(also referred to as hybridization) and elongation is repeatedly passedthrough and preferably in this sequence. In addition it is preferablefor each of the steps to be of equal length in all passages of thecycle. However, this is by no means necessary. One or more of the stepsin one passage of the cycle can, by all means, have a shorter durationthan in another passage of the cycle. The duration t_(c) of a passage ofthe cycle is referred to below as a cycle duration. The object accordingto the invention is achieved by a method for the amplification ofnucleic acids by means of a PCR, wherein the cycle duration t_(c) isless than 20 seconds in at least one passage of the cycle.

The object is achieved also by a method for the amplification of nucleicacids by means of a polymerase chain reaction, wherein a cycleconsisting of the steps: denaturing, annealing and elongation isrepeatedly passed through, wherein the cycle duration t_(c) is reducedby the factor x with respect to the cycle duration of a referencepolymerase chain reaction that is otherwise carried out identically,such that the yield (g) of specimens of a nucleic acid to be amplifiedat the end of at least one of the passages of the cycle is reduced, withrespect to the yield of a reference PCR that is otherwise identicallycarried out, by the factor y, wherein the following applies: x>0.9y andg<80%.

A nucleic acid to be amplified is referred to below as an original.Another common term is “amplicon”. The original is a single strand andcan form, in the reaction volume, together with its complementarystrand, which is described as a complement, a double strand. After eachpassage of the cycle a copy produced of the original is an original forthe next passage of the cycle and a copy produced of the complement is acomplement for the next passage of the cycle. In a passage of the cyclethe number of specimens of the original and complement can be increased.The ratio of specimens of the original newly produced in one passage ofthe cycle to specimens of the original present directly before the cycleis described as the yield g of a passage of a cycle. In theory, in a PCRthe number of originals per passage of the cycle can be doubled, thus ayield g of 100% achieved. In actual fact, however, the yield isgenerally less than 100%.

The cycle can be passed through repeatedly until the desired degree ofamplification is reached. If, at the start of the PCR, N₀ original DNAmolecules are contained in the reaction volume, and if g remainsconstant over the duration T of the whole PCR, hereinafter referred toas the process duration, N_(k) DNA molecules with the sequence of theoriginal are present in the reaction volume after k passages of thecycle:

N _(k) =N ₀*(1+g)^(k).  (1)

The yield g can be calculated as follows from the determination of theamplification factor N_(k)/N₀:

g=(N _(k) /N ₀)^(1/k)−1.  (2)

For simplification, it is assumed here that the yield g per cycleremains constant during the PCR. In general, this assumption shouldapply in any case as long as no saturation effects arise, for examplethrough the consumption of reaction partners.

The process duration T of the PCR that is required in order to reach adesired degree of amplification depends upon the duration of eachpassage of the cycle, hereinafter referred to as the cycle durationt_(c), and also upon the yield. A long cycle duration also increases theprocess duration. However, a low yield also increases the processduration, because it requires more passages of the cycle.

The invention utilises, firstly, the fact that the yield that can beachieved in a passage of the cycle generally depends upon the cycleduration, to which the duration of effect T_(A) substantiallycontributes. The theoretically achievable value of 100% yield per cyclethus requires that all originals successfully pass through all the stepsof denaturing, annealing and elongation. This can no longer be ensuredwith an increasing shortening of the passage of the cycle, e.g. theremay instead be only partial annealing or only partial elongation or onlypartial denaturing. The invention further utilises the finding of theinventors that the advantage of shortening the duration of a passage ofa cycle can outweigh the disadvantage of a lower yield, in such a waythat, despite the lower yield per passage of the cycle, the processduration required for a desired degree of amplification can beshortened.

The method according to the invention takes place in a chamber which isreferred to below as the reaction volume. The reaction volume can beenclosed by a reaction vessel. The reaction volume contains a sample, inwhich usually the nucleic acid(s) to be amplified is/are present. Thesample can include a liquid, preferably water. The cycles of the methodaccording to the invention are passed through at least in a part of thesample. The liquid can advantageously serve as a suspension mediumand/or solvent for the originals and complements and/or otherconstituent parts of the sample.

The denaturing step serves to denature a nucleic acid double strand,i.e. to separate it into its two single strands. For example, theoriginal can be separated from the complement in the denaturing step.Denaturing is also referred to as melting. The denaturing of the nucleicacid double strand is usually thermally induced, i.e. at least a part ofthe nucleic acid double strand or the whole double strand is exposed toa temperature, described as a denaturing temperature, which causes or atleast encourages a separation of the nucleic acid double strands. Thedenaturing temperature does not have to be a fixed temperature but canalso be a temperature interval, within which the temperature in thedenaturing step varies. The preferred denaturing temperature is selectedon the one hand to be so high that nucleic acid double strands can beseparated. On the other hand the preferred denaturing temperature isselected to be so low that a DNA polymerase, which is possibly alsolocated in the sample, is not substantially damaged. A typical value forthe denaturing temperature is 95° C.

The reaction volume further contains preferably at least twooligonucleotides, which are described as primers. One of these primersis described as a forward primer and another as a reverse primer. Theforward primer is complementary to the 3′-end of the original. Thereverse primer is complementary to the 3′-end of the complement.Annealing is understood to be the hybridization of the forward primerswith the original and the reverse primers with the complement. Theannealing step serves for the hybridization of the forward and reverseprimers to their complementary sequences in the original or complement.The annealing is also usually thermally induced, i.e. at least a part ofthe original or the complement, or the whole original or the wholecomplement, is exposed to a temperature which is described as theannealing temperature, which causes or at least encourages ahybridization of the forward and reverse primers to their complementarysequences in the original or complement. Like the denaturingtemperature, the annealing temperature can also be a temperature range,within which the temperature varies in the annealing step. The annealingstep typically takes place at temperatures of 50° C. to 65° C. Theannealing temperature is selected so that a hybridization of the primersthat is as specific as possible can take place.

Hybridization means in the sense of the present invention the formationof a double strand from two single strands, which can each consist of anucleic acid and/or an oligonucleotide. Under suitable reactionconditions the hybridization generally leads to the lowest possibleenergy state that can be achieved by the combination of the two singlestrands. In other words, under suitable conditions, the two singlestrands preferably bind to each other in such a way that, with respectto the sequences of the two single strands, the greatest possiblecomplementarity (i.e. specificity) is produced.

If a nucleic acid A is partially complementary to a nucleic acid B, thismeans that the nucleic acid A is complementary in one part to a part ofthe nucleic acid B.

The terms “nucleic acid” and “oligonucleotide” include in the context ofthe present invention not only (desoxy)-ribonucleic acids and(desoxy)-oligoribonucleotides, but also nucleic acids andoligonucleotides that contain one or more nucleotide analogues withmodifications on their backbone (e.g. methylphosphonates,phosphorothioates or peptic nucleic acids (PNA), in particular on asugar of the backbone (e.g. 2′-O-alkyl derivatives, 3′- and/or5′-aminoriboses, locked nucleic acids (LNA), hexitol nucleic acids,morpholinos, glycol nucleic acid (GNA), threose nucleic acid (TNA) ortricyclo-DNA—see in this connection the dissertation by D. Renneberg andC. J. Leumann, “Watson-Crick base-pairing properties of Tricyclo-DNA”,J. Am. Chem. Soc., 2002, Volume 124, pages 5993-6002, of which therelated content is part of the present disclosure through referencethereto) or that contain base analogues, e.g. 7-deazapurine or universalbases such as nitroindole or modified natural bases such asN4-ethyl-cytosine. In one embodiment of the invention the nucleic acidsor oligonucleotides are conjugates or chimera with non-nucleosideanalogues, e.g. PNA. The nucleic acids or oligonucleotides contain inone embodiment of the invention, at one or more positions,non-nucleoside units such as spacers, e.g. hexaethylene glycol orC_(n)-spacers with n between 3 and 6. If the nucleic acids oroligonucleotides contain modifications these are selected so that, alsowith the modification, hybridization with natural DNA/RNA analytes ispossible. Preferred modifications influence the melt behaviour,preferably the melt temperature, in particular in order to be able todifferentiate hybrids with different degrees of complementarity of theirbases (mismatch discrimination). Preferred modifications include LNA,8-aza-7-deazapurine, 5-propinyl-uracil and cytosine and/or abasicinterruptions or modifications in the nucleic acid or in theoligonucleotide. Further modifications in the sense of the inventionare, e.g., modifications with biotin, thiol and fluorescence donor andfluorescence acceptor molecules.

An abasic modification in the sense of the present invention is aportion of the oligonucleotide, in which the sequence of nucleotides isinterrupted by the introduction of one or more molecules that do notconstitute nucleotides, in such a way that a polymerase completely orpartially interrupts the synthesis of an otherwise completely orpartially hybridized, complementary oligonucleotide with respect to thisportion, as there is insufficient base complementarity on this portion.An abasic modification is preferably selected from the group thatincludes: 1′,2′-dideoxyribose (dSpacer), hexaethylene glycol (Spacer18)and triethylene glycol (Spacer9).

The reaction volume further contains preferably a DNA polymerase. TheDNA polymerase can synthesize, in an elongation step starting from theforward primer, a copy of the complement. Starting from the reverseprimer the DNA polymerase can synthesize a copy of the original. Throughthe synthesis the copy of the complement is hybridized with the originaland the copy of the original is hybridized with the complement. For thepurpose of elongation the DNA polymerase is exposed to a temperature,described as the elongation temperature, which allows or at leastencourages an elongation. The elongation temperature can also be atemperature range, within which the temperature varies in the elongationstep. When using a polymerase of Thermus aquaticus (Taq), an elongationtemperature of 72° C. is typically used. In some embodiments of the PCRthe annealing temperature and the elongation temperature are identical,i.e. both steps take place at the same temperature.

In a preferred embodiment, at least two steps of the PCR are performedat different temperatures, meaning that it may be necessary to provideone or more heating steps and/or cooling steps in the cycle, in whichthe reaction volume or parts of the reaction volume are heated orcooled. A heating or cooling step can take place before or after one ofthe steps of denaturing, annealing and elongation. A heating or coolingstep thereby typically overlaps with the preceding and/or the subsequentdenaturing, annealing or elongation step.

In the sense of the present invention the duration of effect t_(A) of apassage of the cycle is the total duration, in which an energy sourceduring the passage of the cycle acts on a point in the sample with apower suitable for denaturing in order to bring about heating in thesample.

The energy source transfers during the whole time t_(A) a power suitablefor denaturing to said point. An energy source in the form of a lasercould be used for example with a higher power for denaturing and for asubsequent extinction measurement with lower power. In this case t_(A)is merely the time, in which the laser transfers the higher powersuitable for denaturing to the point.

If a plurality of energy sources are used for denaturing, t_(A)preferably refers to the time, in which all energy sources fordenaturing act simultaneously on the point. In the case of activation ofa plurality of energy sources, frequently the denaturing will beachieved only with the simultaneous action.

Said point is thereby determined within the part of the sample, in whichthe method is carried out, so that t_(A) assumes the greatest possiblevalue. If therefore the heating is produced, for example, by a fixedPeltier element, t_(A) is the total duration, in which heat flows fromthe Peltier element in this cycle to this point and brings about atemperature increase there that is suitable for denaturing (typicallyapproximately the switch-on duration during the heating step; in anycase shorter than the cycle duration). If the heating is produced by alight beam with the diameter d, which is guided (scanned) with a speed vthrough the sample volume, t_(A) is the time duration

$\frac{d}{v},$

during which the light beam hereby acts on a point in the sample with apower suitable for denaturing. If the heating is produced by a pulsedlight source, of which the light beam is not moved relative to thesample during the pulse duration, the pulse duration is the duration ofeffect. If the heating is produced by a pulsed light source which isscanned through the sample, the shorter of the two durations (pulseduration and time duration

$\left. \frac{d}{v} \right)$

is the duration of effect.

Through the selection according to the invention of particularly lowvalues of the duration of effect t_(A) and cycle duration t_(c), aparticularly rapid PCR method can be realised. In the case of a shortduration of effect, numerous cycles can be passed through in a shorttime, so that a low yield can also be taken into account. Through thehigh number of cycles according to the invention, a greateramplification of the amplicon can advantageously be achieved.

Preferred Embodiments of the Invention

In a preferred embodiment of the invention a heating step takes placebefore the denaturing step, preferably overlapping with the denaturingstep. In the heating step, the temperature in the denaturing step withrespect to the temperature in the elongation step is increasedpreferably at least locally, i.e. in certain areas of the reactionvolume, in order to facilitate denaturing. Through the effect of theenergy source at least in these areas, preferably a temperature of atleast 90° C., particularly preferably at least 95° C., is reached.

In a preferred embodiment of the invention a cooling step takes placebefore the annealing step, particularly preferably overlappingtherewith, in order to reach the temperature required for annealing. Ifthe temperature in the previous denaturing step was only locallyincreased, the cooling preferably takes place through heat diffusion inthe reaction volume.

The part of the sample, in which the cycles of the method according tothe invention are passed through, contains preferably at least 1%,particularly preferably at least 2%, particularly preferably at least5%, particularly preferably at least 10% and more particularlypreferably at least 20%, of the total sample volume. At the same time,said part preferably contains maximum 100%, particularly preferablymaximum 80%, particularly preferably maximum 60% and more particularlypreferably maximum 40%, of the total sample volume. An acceleration ofthe method can be achieved by the cycles being passed through in only apart of the sample.

The yield g of specimens of a nucleic acid to be amplified ispreferably, at the end of at least one of the passages of the cycle—in apreferred embodiment of the invention at the end of each of 10,particularly preferably of each of 20, particularly preferably each of40, particularly preferably each of 80, particularly each of 160passages of the cycle—less than 70%, particularly preferably less than60%, particularly preferably less than 50%, particularly preferably lessthan 40%, particularly preferably less than 30%, particularly preferablyless than 20%, particularly preferably less than 10%, particularlypreferably less than 5%, particularly preferably less than 2%,particularly preferably less than 1%, particularly preferably less than0.5%, of the specimens of the nucleic acid present at the start of thispassage of the cycle. This embodiment of the invention utilises the factthat, in particular in the case of particularly low yields, but stillwith a corresponding selection of the duration of a cycle, aparticularly advantageous short process duration can be achieved.

The duration of effect t_(A) in at least one of the passages of thecycle—in a preferred embodiment of the invention in at least 10 passagesof the cycle, particularly preferably in at least 20, particularlypreferably in at least 40, particularly preferably in at least 80,particularly preferably in at least 160 passages of the cycle—ispreferably shorter than 10 s, particularly preferably shorter than 5 s,particularly preferably shorter than 3 s, particularly preferablyshorter than 1 s, particularly preferably shorter than 500 ms(milliseconds), particularly preferably shorter than 250 ms,particularly preferably shorter than 100 ms, particularly preferablyshorter than 50 ms, particularly preferably shorter than 25 ms,particularly preferably shorter than 10 ms, and more particularlypreferably shorter than 8 ms, particularly preferably shorter than 3 ms,particularly preferably shorter than 1 ms, particularly preferablyshorter than 500 μs, particularly preferably shorter than 300 μs,particularly preferably shorter than 100 μs, particularly preferablyshorter than 50 μs, particularly preferably shorter than 30 μs,particularly preferably shorter than 10 μs. This embodiment of theinvention utilises the fact that, in particular through a particularlyshort duration of effect t_(A), a particularly advantageously shortprocess duration can be achieved.

In a preferred embodiment of the invention, the yield g of specimens ofa nucleic acid to be amplified is, at the end of at least one of thepassages of the cycle—in a preferred embodiment of the invention at theend of each of 10 passages of the cycle, particularly preferably each of20, particularly preferably each of 40, particularly preferably each of80, particularly each of 160 passages of the cycle—less than 80%, lessthan 70%, less than 60%, less than 50%, less than 40%, less than 30%,particularly preferably less than 20% or 10%, particularly preferablyless than 5%, particularly preferably less than 1%, of the specimens ofthe nucleic acid present at the start of this passage of the cycle, and,at the same time, in this passage or these passages of the cycle, theduration of effect t_(A) is shorter than 5 seconds, particularlypreferable shorter than 3 s, particularly preferably shorter than 1 s,particularly preferably shorter than 250 ms, particularly preferablyshorter than 50 ms, particularly preferably shorter than 10 msparticularly preferably shorter than 3 ms, particularly preferablyshorter than 1 ms, particularly preferably shorter than 300 μs,particularly preferably shorter than 100 μs, particularly preferablyshorter than 30 μs, particularly preferably shorter than 10 μs. Thisembodiment of the invention utilises the fact that particularlyadvantageously short process durations can be achieved if a particularlylow yield goes hand in hand with a particularly short duration ofeffect.

The yield g of specimens of a nucleic acid to be amplified ispreferably, at the end of at least one of the passages of the cycle—in apreferred embodiment of the invention at the end of each of 10 passagesof the cycle, particularly preferably each of 20, particularlypreferably each of 40, particularly preferably each of 80, particularlypreferably each of 160 passages of the cycle—more than 0.1%,particularly preferably more than 1%, particularly preferably more than10%, of the specimens of the nucleic acid present at the start of thispassage of the cycle. This embodiment of the invention utilises the factthat a yield that is not too low for each passage of the cycle canreduce the probability of errors in the amplification and can thusensure a more reliable amplification result.

The duration of effect t_(A) in at least one of the passages of thecycle—in a preferred embodiment of the invention in at least 10,particularly preferably in at least 20, particularly preferably in atleast 40, particularly preferably in at least 80, particularlypreferably in at least 160 passages of the cycle—is preferably longerthan 1 μs, particularly preferably longer than 30 ps, particularlypreferably longer than 100 ps, particularly preferably longer than 300ps, particularly preferably longer than 1 ns, particularly preferablylonger than 10 ns, particularly preferably longer than 100 ns,particularly preferably longer than 300 ns, particularly preferablylonger than 1 ps, particularly preferably longer than 3 ps, particularlypreferably longer than 10 μs. Through a moderate duration of effect, amore reliable denaturing can advantageously be achieved, in particularas the unravelling of a DNA double strand and a sufficient increase inthe distance between the two strands through diffusion (to avoidre-hybridization), can require a sufficiently high temperature to bemaintained for a certain time period of time.

In a preferred embodiment of the invention, the yield g of specimens ofa nucleic acid to be amplified is, at the end of at least one of thepassages of the cycle—in a preferred embodiment of the invention at theend of each of 10, particularly preferably each of 20, particularlypreferably each of 40, particularly preferably each of 80, particularlyeach of 160 passages of the cycle—more than 0.1%, particularlypreferably more than 1%, particularly preferably more than 10%, of thespecimens of the nucleic acid present at the start of this passage ofthe cycle, and, at the same time, in this passage or these passages ofthe cycle the duration of effect t_(A) is longer than 1 ps, particularlypreferably longer than 30 ps, particularly preferably longer than 300ps, particularly preferably longer than 1 ns, particularly preferablylonger than 10 ns, particularly preferably longer than 100 ns,particularly preferably longer than 300 ns, particularly preferablylonger than 1 μs, particularly preferably longer than 3 μs, particularlypreferably longer than 10 μs, particularly preferably longer than 30 μs,particularly preferably longer than 100 μs, particularly preferablylonger than 300 μs, particularly preferably longer than 1 ms,particularly preferably longer than 3 ms and more particularlypreferably longer than 5 ms. This embodiment of the invention utilisesthe fact that a particularly more reliable amplification result can beachieved when a yield that is not too low goes hand in hand with asufficiently long duration of effect.

The product g·t_(c) of the yield g and the cycle duration t_(c) isdescribed as the characteristic super-amplification time constant. Thischaracteristic super-amplification time constant is preferably, at theend of at least one of the passages of the cycle—in a preferredembodiment at the end of each of 10, particularly preferably each of 20,particularly preferably each of 40, particularly preferably each of 80,particularly preferably each of 160 passages of the cycle—less than 20s, particularly preferably less than 15 s, particularly preferably lessthan 12 s, particularly preferably less than 10 s, particularlypreferably less than 8 s, particularly preferably less than 6 s,particularly preferably less than 4 s, particularly preferably less than2 s. It is an achievable advantage of such embodiments of the inventionthat the PCR protocol is shortened. The invention is based on the ideathat shorter cycle durations lead to a smaller increase per cycle, butthis can be overcompensated, in the case of shortened duration of thewhole protocol, by adding additional cycles.

According to the invention a cycle duration t_(c)—in a preferredembodiment each of 10, particularly preferably each of 20, particularlypreferably each of 40, particularly preferably each of 80, particularlypreferably each of 160 passages of the cycle—is selected, which isshortened by the cycle shortening factor x with respect to the cycleduration t_(ch) of an otherwise identically carried out reference PCR

$\left( {\frac{t_{c_{h}}}{x} = t_{c}} \right).$

The reference PCR reaction is thereby in particular identical, withrespect to the biochemical composition, the maintaining of the identicalannealing, elongation and denaturing temperature and above all withrespect to the target nucleic acid to be amplified and especially itssequence, concentration and pre-treatment. With the reference PCR, it issolely that the cycle duration is longer and the number of cycles maypossibly be higher. This leads according to the invention to a yield percycle g which, in comparison with the yield per cycle of the otherwiseidentically performed reference PCR, PIC g_(h), is reduced by theefficiency loss factor PIC

$\left( {\frac{g_{h}}{y} = g} \right).$

In one embodiment the following applies: x>0.9y, particularly preferablyx=y, particularly preferably x>y, particularly preferably x>1.1y,particularly preferably x>1.2y, particularly preferably x>1.3y,particularly preferably x>1.5y, particularly preferably x>2y,particularly preferably x>2.5y, particularly preferably x>3y,particularly preferably x>5y, wherein at the same time it is preferablythe case that x>1.2, particularly preferably x>1.5, particularlypreferably x>2, particularly preferably x>2.5, particularly preferablyx>3, particularly preferably x>4, particularly preferably x>5,particularly preferably x>10.

It can hereby be achieved that the “compound interest effect”, which isfacilitated by x times more cycles per time unit, more than compensatesfor the efficiency loss (i.e. by the yield per cycle reduced by thefactor y) in the PCR according to the invention, i.e. that according tothe invention more amplicon can be produced during a PCR of equal lengthor even a PCR of shorter length.

In the PCR according to the invention, more cycles are therebypreferably passed through than in the reference PCR, wherein the PCRaccording to the invention preferably passes through x times more cycles(x is the cycle shortening factor), particularly preferably 0.9× more,particularly preferably 0.8× more, particularly preferably 0.6× more,particularly preferably 0.4× more, particularly preferably 0.2× morecycles, and more particularly preferably 0.1× more cycles. It can herebybe achieved that the duration of the protocol is shorter than in thereference PCR, as the cycle duration is shortened by the cycleshortening factor x, but the number of required cycles and thus theduration of the whole protocol does not increase to the same extent.

In one embodiment the cycle shortening factor of the PCR according tothe invention is, with respect to the reference PCR, preferably at leastx>1.2, particularly preferably at least x>1.5, particularly preferablyat least x>2, particularly preferably at least x>3, particularlypreferably at least x>4, particularly preferably at least x>5, and moreparticularly preferably at least x>10. It can hereby be achieved that asignificant “compound interest effect” or super-amplification effectarises.

For the solution according to the invention, the PCR must not yet havereached a saturation state, such as can arise, e.g. through theconsumption of the limiting reactants (e.g. the primers or dNTPs), assuch saturation effects can lead to a reduction in the yield per cyclein the course of the PCR. It is therefore provided in a preferredembodiment of the invention that the concentration of the limitingreactant, since the start of the PCR, has decreased by less than 80%,particularly preferably by less than 50%, particularly preferably byless than 25%, particularly preferably by less than 10%, particularlypreferably by less than 5%, particularly preferably by less than 1%,particularly preferably by less than 0.1%.

It is also possible to ensure that saturation effects are avoided inthat the yield per cycle is preferably extensively constant over thecourse of the PCR—in a preferred embodiment of the invention at the endof each of 10, particularly preferably each of 20, particularlypreferably each of 40, particularly preferably each of 80, particularlypreferably each of 160 passages of the cycle, is preferably still atleast 95%, particularly preferably 90%, particularly preferably 80%,particularly preferably 70%, particularly preferably 50%, particularlypreferably 20%, particularly preferably 10% of the yield of the cyclethat had the highest yield during the PCR (typically the 1^(st) cycle).

Such saturation effects can also be avoided by limiting the solutionaccording to the invention to preferably the first 80%, particularlypreferably first 50%, particularly preferably first 25%, particularlypreferably first 10%, of all passages of the cycle to be carried out ina PCR.

It is preferred that the number k of the passages of the cycle isgreater than 45, particularly preferably greater than 50, particularlypreferably greater than 60, particularly preferably greater than 70,particularly preferably greater than 80, particularly preferably greaterthan 90, particularly preferably greater than 100, particularlypreferably greater than 120, particularly preferably greater than 160and more particularly preferably greater than 200. Advantage is therebytaken of the fact that the positive effect of shortening the duration ofthe individual passages of the cycle becomes noticeable particularlywhen the number of passages is high.

The number k of the passages of the cycle is preferably less than 1000,particularly preferably less than 750 and more particularly preferablyless than 500. Advantage is hereby taken of the fact that a number ofpassages that is not too high can have a positive effect on thereliability of the amplification result.

The abbreviations “M”, “mM”, “μM”, “nM”, “pM” and “fM”, as given below,stand for the units: mol/l, mmol/l, pmol/l, nmol/l, pmol/l or fmol/l.

The concentration of the amplicon to be amplified is, at the start ofthe method, preferably greater than zero, preferably greater than 10⁻²³M (mol/l), particularly preferably greater than 10⁻²¹ M, particularlypreferably greater than 10⁻²⁰ M, particularly preferably greater than10⁻¹⁹ M. It can advantageously be achieved through this embodiment ofthe invention that the amplification is sufficiently sensitive toproduce an amount of amplification products that can be suitablydetected.

The concentration of the amplicon to be amplified in the PCR ispreferably less than 1 nM, particularly preferably less than 30 pM,particularly preferably less than 1 pM, particularly preferably lessthan 0.1 pM, particularly preferably less than 10 fM, particularlypreferably less than 1 fM, particularly, preferably less than 0.1 fM.Through this embodiment of the method it is advantageously possible toprevent the amplification already reaching saturation before its end.

The number of amplicons to be amplified in the method is, at the startof the method, preferably less than 500,000, particularly preferablyless than 200,000, particularly preferably less than 100,000,particularly preferably less than 10,000. Through this embodiment of theinvention it is advantageously possible to prevent the amplificationalready reaching saturation before its end.

An important parameter of the invention can be the total duration t_(c)of a passage of the cycle, thus the cycle duration. In particular it maybe possible—despite a long duration of effect t_(A)- to achieve anadvantageously short cycle duration by saving time at another point,e.g. a short annealing duration due to a high primer concentration inthe sample or a short elongation time with the aid of a rapid DNApolymerase. The cycle duration t_(c) is preferably in at least one ofthe passages of the cycle—in a preferred embodiment of the invention inat least 10, particularly preferably in at least 20, particularlypreferably in at least 40, particularly preferably in at least 80,particularly preferably in at least 160 passages of the cycle, shorterthan 40 s, particularly preferably shorter than 30 s, particularlypreferably shorter than 20 s, particularly preferably shorter than 15 s,particularly preferably shorter than 12.5 s, particularly preferablyshorter than 10 s, particularly preferably shorter than 7.5 s,particularly shorter than 5 s, particularly preferably shorter than 4 s,particularly preferably shorter than 3 s, particularly preferablyshorter than 2 s and more particularly preferably shorter than 1 s.

On the other hand a passage of the cycle that is too fast can have anegative effect on the reliability of the amplification result.Therefore, in a preferred embodiment of the invention, the cycleduration t_(c) preferably in at least one of the passages of thecycle—in a preferred embodiment of the invention in at least 10,particularly preferably in at least 20, particularly preferably in atleast 40, particularly preferably in at least 80, particularlypreferably in at least 160 passages of the cycle—is longer than 0.5 s,particularly preferably longer than 1 s, particularly preferably longerthan 2 s, particularly preferably longer than 3 s, particularlypreferably longer than 4 s, particularly preferably longer than 5 s.

The method according to the invention can advantageously be used inparticular in larger volumes of samples, inter alia, because forstatistical reasons a sufficient number of correct duplicates are stillproduced with greater reliability even with short cycle times.Preferably in at least one of the passages of the cycle—in a preferredembodiment of the invention in at least 10, particularly preferably inat least 20, particularly preferably in at least 40, particularlypreferably in at least 80, particularly preferably in at least 160passages of the cycle—the quotient

$\frac{t_{A}}{V_{r}}$

of the duration of effect t_(A) and the reaction volume V_(r) irradiatedby the energy source is less than 1 s/μl (seconds per microlitre), i.e.<1 s/μl, particularly preferably less than 0.1 s/μl, particularlypreferably less than 0.01 s/μl and more particularly preferably lessthan 0.001 s/μ1.

On the other hand it can be advantageous inter alia for themanageability of the method if in at least one of the passages of thecycle—in a preferred embodiment of the invention in at least 10,particularly preferably in at least 20, particularly preferably in atleast 40, particularly preferably in at least 80, particularlypreferably in at least 160 passages of the cycle—the quotientt_(A)/V_(r) of the duration of effect t_(A) and the reaction volumeV_(r) irradiated by the energy source is greater than 1 ps/μl,particularly preferably greater than 10 ps/μl, particularly preferablygreater than 100 ps/μl, particularly preferably greater than 1 ns/μl,particularly preferably greater than 10 ns/μl and more particularlypreferably greater than 100 ns/μl.

The energy source, which preferably produces global heating and,particularly preferably, local heating in the reaction volume is anelectromagnetic radiation source, particularly preferably a lightsource, in a preferred method. A preferred light source emits light toheat the reaction volume preferably in the spectral range 200-2000 nm,particularly preferably in the range 300-1600 nm, particularlypreferably in the range 300-1100 nm and most particularly preferably inthe range 400-800 nm. The energy source is more particularly preferablya laser, e.g. a continuous or quasi-continuous diode laser or solid bodylaser or a nanosecond laser.

The invention is particularly well suited for the amplification ofnucleic acids that are shorter than 2000 bases, particularly preferablyshorter than 1000 bases, particularly preferably shorter than 300 bases,particularly preferably shorter than 200 bases, particularly preferablyshorter than 150 bases, particularly preferably shorter than 100 bases,particularly preferably shorter than 80 bases, and more particularlypreferably shorter than 60 bases. The amplicon to be amplified ispreferably longer than 10 bases, particularly preferably longer than 30bases and more particularly preferably longer than 50 bases. The methodaccording to the invention can amplify DNA in said lengths particularlyeffectively.

Advantageously short cycle durations can be achieved, inter alia, by arapid elongation. A DNA polymerase is preferably selected and thereaction conditions of the PCR set so that the DNA polymerase has awrite speed of at least 1 base/s, particularly preferably at least 5bases/s, particularly preferably at least 10 bases/s, particularlypreferably at least 50 bases/s, particularly preferably at least 100bases/s, particularly preferably at least 500 bases/s and moreparticularly preferably at least 1000 bases/s.

In a preferred embodiment of the invention nanoparticles in a reactionvolume transfer heat to their environment through excitation. Thenanoparticles are preferably particles which, due to their size, haveparticular optical properties, e.g. characteristic absorption orscattering spectra, which do not emerge, or do not emerge so clearly, inthe volume material. The nanoparticles preferably have a diameter ofbetween 2 and 500 nm (nanometres), particularly preferably between 3 and300 nm and more particularly preferably between 5 and 200 nm. Preferrednanoparticles have a diameter of between 7 and 150 nm. The nanoparticlescan be spherical, but in particular also non-globular forms, e.g.elongated nanoparticles (nanorods), can also be considered. In apreferred embodiment of the invention the nanoparticle comprises atleast one semiconductor or a metal, preferably a precious metal, e.g.gold or silver. In one embodiment the nanoparticle consists completelyof the metal, in another embodiment the metal forms only a part of thenanoparticle, e.g. its shell. A preferred nanoparticle may be ashell-core nanoparticle. A preferred nanoparticle may have pores at itssurface, which may be occupied by atoms or molecules with a size andcharge determined by the properties of the pores. These atoms ormolecules particularly preferably attach themselves to the nanoparticleonly when it is in a solution. According to the invention thenanoparticle also comprises the atoms and molecules taken up at itssurface. Preferred nanoparticles are suited, due to their materialabsorption or plasmon resonance, for absorbing optical energy.

The heating time is the time that passes after the excitation intensityI(t) of the light source has reached its maximum value in therespectively excited volume until a temperature is set at each point inthe excited volume that changes, even if the duration of effect isdoubled, by maximum 3° C.

The cooling time is the time period after the switch-off point of theexcitation light source that passes until at each point in the volumeunder observation a temperature is set that deviates by maximum 3° C.from the temperature before the effect.

The switch-off time point t_(off) of the excitation light source isdefined as the point in time, at which the excitation intensity I in thevolume under observation has decreased to less than 5% of the maximumexcitation intensity (e.g. after the pulse of a laser).

Determination of the heating and cooling time: The evolution of thetemperature over time at a distance r from the centre of a nanoparticlehaving radius rNP is obtained by numerically solving the heat conductionequation in a sufficiently large water sphere having radius rMax aroundthe nanoparticle, wherein the nanoparticle itself is removed from thesimulation area. By utilizing spherical symmetry, a one-dimensionalradial heat conduction equation is obtained, in the area rNP to rMax,t>0:

${{\frac{\alpha}{r^{2}}{\partial_{r}\left( {r^{2} \cdot {\partial_{r}{T\left( {r,t} \right)}}} \right)}} = {\partial_{t}{T\left( {r,t} \right)}}},$

wherein T(r,t) is the temperature at the position r at the time t and ais the thermal diffusivity of the water (α=1.43·10⁻⁷ m²/s).

As a starting condition the temperature of the surrounding medium is setbefore optical excitation to T₀: T(r, 0)=T₀.

The boundary conditions at the positions rNP and rMax are set asfollows: At the position r=rNP the increase of the temperatureprogression at the point in time t is obtained from the absorbed powerof the nanoparticle at the point in time t (Neumann boundary condition):

∂_(r) T(rNP,t)=P(t)/(4·π·rNP ² ·k)

wherein P(t) is the power absorbed by the nanoparticle and k is thethermal conductivity of water (k=0.6 W/(m·K). The absorbed power iscalculated from P(t)=I(t)·σ, with I(t) corresponding to thetime-dependent excitation intensity of the light source and theabsorption cross-section of the part a (i.e. provided that the focussize is not changed, I(t) for example for a CW laser would be aconstant, and I(t) would reproduce the time-dependent pulse form for apulsed laser).

At the position rMax the temperature is kept constant (T(rMax,t)=T₀(Dirichlet boundary condition). For rNP<100 nm, for example rMax 10,000nm is selected. The thermal diffusivity and thermal conductivity of thewater is assumed as a constant. In general, α=k/(C·p) applies, wherein Cis the specific heat capacity and p is the density of water.

By means of suitable programs for the numerical solution of such partialdifferential equations (e.g. with the command NSolve in mathematics,etc.) the above heat conduction equation can be solved and valuesobtained for the temperature as a function of the location and the timeT(r,t).

For example, for a spherical gold nanoparticle with rNP=30 nm, which isexcited with a constant intensity of 1 kW/mm² with 532 nm wavelength fora duration of 100 ns, the following values are obtained for a startingtemperature of T₀=30° C.: T(r=30 nm, t=20 ns)=70° C., T(r=30 nm, t=100ns)=78° C., T(r=30 nm, t=120 ns)=36° C., T(r=40 nm, t=20 ns)=56° C.,T(r=40 nm, t=100 ns)=64° C., T(r=40 nm, t=120 ns)=36° C.

To determine the heating time according to the invention T(r,t) isevaluated for different times. The heating time is then the shortesttime_(taut), for which the following applies:

|T(r,t _(auf))−T(r,2·t _(auf))|≤3° C. with r∈[rNP;rMAX]

i.e. the amount of the difference of the temperature distribution forthe times t_(auf) and 2t_(auf) must be less than 3° C. for all pointsoutside of the nanoparticle.

The cooling time is obtained as a difference t_(x)−t_(off), whereint_(x) is the shortest time, for which the following applies:

|T(r,t _(x))−T ₀|≤3° C. with r∈[rNP;rMAX] and t _(x) >t _(off).

The heating time preferably in at least one of the passages of thecycle—in a preferred embodiment of the invention in at least 10,particularly preferably in at least 20, particularly preferably in atleast 40, particularly preferably in at least 80, particularlypreferably in at least 160 passages of the cycle—is preferably more than1 nanosecond, particularly preferably more than 5 nanoseconds,particularly preferably more than 10 nanoseconds and preferably lessthan 100 milliseconds, particularly preferably less than 10milliseconds, particularly preferably less than 1 millisecond,particularly, preferably less than 300 microseconds, particularlypreferably less than 100 microseconds, particularly preferably less than50 microseconds, particularly preferably less than 30 microseconds,particularly preferably less than 10 microseconds, particularlypreferably less than 5 microseconds, particularly preferably less than1.5 microseconds. Through a short heating time, a short total durationof the method can be achieved.

The cooling time preferably in at least one of the passages of thecycle—in a preferred embodiment of the invention in at least 10,particularly preferably in at least 20, particularly preferably in atleast 40, particularly preferably in at least 80, particularlypreferably in at least 160 passages of the cycle, is preferably morethan 1 nanosecond, particularly preferably more than 5 nanoseconds,particularly preferably more than 10 nanoseconds and preferably lessthan 100 milliseconds, particularly preferably less than 10milliseconds, particularly preferably less than 1 millisecond,particularly preferably less than 300 microseconds, particularlypreferably less than 100 microseconds, particularly preferably less than50 microseconds, particularly preferably less than 30 microseconds,particularly preferably less than 10 microseconds, particularlypreferably less than 5 microseconds, particularly preferably less than 3microseconds, particularly preferably less than 1.5 microseconds,particularly preferably less than 1 microsecond, particularly preferablyless than 300 nanoseconds, particularly preferably less than 100nanoseconds. A short cooling time can contribute to an accelerated PCR.

If, through excitation of a nanoparticle, heat is transferred to itsenvironment, this means that energy is transferred to the nanoparticle,wherein the nanoparticle heats its environment through the transfer ofthe energy. Through the excitation of the nanoparticles, the directenvironment of the nanoparticles is preferably heated more than the moredistant environment of the nanoparticles. Usually the nanoparticles areinitially heated by excitation and then transfer heat to theirenvironment. The environment of the nanoparticles is preferably aspherical volume which has 100 times (100×) the diameter of thenanoparticle located at its centre point, particularly preferably 10×the diameter, more particularly preferably 4× the diameter andpreferably less than 2× the diameter.

Through the excitation of the nanoparticles the environment of thenanoparticles is preferably locally heated. Particularly rapidtemperature changes are possible if the heated volume only accounts fora small fraction of the total volume. On the one hand, with just a smallenergy input through irradiation, a high temperature difference canalready be produced. On the other hand, a very rapid cooling of theheated volume is possible if a sufficiently large cold temperature tankis present in the irradiated volume in order to cool the nanoparticlesand their environment again after the irradiation. This can be achievedby the nanoparticles being irradiated sufficiently greatly (in order toreach the desired temperature increase) and sufficiently shortly (inorder that the heat remains localized). It is possible through localheating to expose the polymerases to a lower heat, so that PCR methodswith a number of cycles exceeding 80 can also be realised.

A local heating in the sense of the present invention is present if theduration of the excitation in the respectively irradiated volume (e.g.in the laser focus) t is selected to be shorter than or equal to acritical excitation duration t1. The excitation duration t1 is herebypreferably equal to the duration of effect t_(A). t1 is herebydetermined by the time required by the heat to diffuse, with an averagenanoparticle distance, from one nanoparticle to the next, multiplied bya scaling factor s1. In the case of an average nanoparticle distance |x|and a temperature conductivity D of the medium between thenanoparticles, t1 is given by:

t1=(s1·|x|)² D,

wherein the temperature conductivity D typically in an aqueous solutionhas a value of D=10⁻⁷ m²/s.

The scaling factor s1 is a measure of how far the heat front of aparticle spreads during the excitation duration. The temperatureincrease through an excited nanoparticle at a distance of a fewnanoparticle diameters is only a very small fraction of the maximumtemperature increase on the particle surface. In one embodiment of theinvention an overlap of the heat fronts of a few nanoparticles isallowed in the sense that, in order to define the critical excitationduration t1 using the abovementioned formula, a scaling factor s1 ofgreater than 1 is used. In another embodiment of the invention, nooverlap of the heat fronts is allowed during the excitation duration(corresponding to a greatly localized heating) in the sense that, inorder to define the critical excitation duration t1 using theabovementioned formula, a scaling factor s1 of less than or equal to 1is used. To define the local heating, preferably s1=100, preferablys1=30, preferably s1=10, preferably s1=7, preferably s1=3 and moreparticularly preferably s1=1, preferably s1=0.7, preferably s1=0.3.

Values for s1>1 can be advantageous, inter alia, for example in suchcases in which the irradiated volume has a high aspect ratio (forexample in the focus of a moderately focused laser beam), so that thereis a comparably high number of nanoparticles located at the surface ofthe irradiated volume, and fewer heated nanoparticles are thereforelocated in their environment, and a significant heat removal from theirradiated volume takes place, so that the heating contribution of themore remote neighbours remains negligible for longer.

This means that, for example in the case of a nanoparticle concentrationof 1 nM, which results in an average nanoparticle distance of |x|=1.2micrometres, local heating is present, insofar as the excitationduration is less than t1=14 microseconds (the scaling factor is selectedhere as s1=1, D=10⁻⁷ m²/s). It is to be assumed that if t>t1 isselected, the heat emitted by the nanoparticles can consequently cover,through diffusion, during the irradiation, a distance that is greaterthan the average nanoparticle distance and this leads as a result to asuperimposition of the heat fronts of many nanoparticles so that atemperature increase takes place in the whole volume between thenanoparticles. The temperature increase should be spatially morehomogeneous in the irradiated volume, the longer it is heated, as notonly the contributions of the closest nanoparticles but also of moreremote neighbours are included in the temperature distribution around ananoparticle. If the reaction volume is irradiated with a radiationabsorbed by the nanoparticles for longer than t1, the heating isdescribed as global.

A global heating can also take place, e.g., in that the reaction volumeis heated from externally with a Peltier element or a resistance heater.The global heating can also be carried out in that, e.g. the reactionvolume is irradiated with a radiation that is absorbed by the water inthe sample more greatly than, or similarly greatly to, its absorption bythe nanoparticles. “Temperature increase” hereby means the differencebetween the temperature at a location at the observation time directlyafter the excitation and the temperature at the same location at thetime directly before the excitation. Global heating and local heatingcan also be carried out simultaneously.

Through the excitation of nanoparticles it can be achieved that in thePCR method of nucleic acids, it is not the whole reaction volume thatmust be heated. On the other hand it is possible to heat only specificparts of the reaction volume through excitation of nanoparticles. It isadvantageously possible to heat only the parts of the reaction volumethat must be heated for the amplification of the nucleic acids. In thisway, heat-sensitive constituent parts of the sample can be protected,such that a higher number of cycles is facilitated. Local heating can bemore rapid than global heating of the whole reaction volume if lessenergy needs to be transferred. Therefore, it is advantageously possiblethrough the invention to provide a PCR method which is quicker andrequires less energy.

The excitation of the nanoparticles preferably takes place through analternating field, particularly preferably through an electromagneticalternating field, more particularly preferably optically. Theexcitation preferably takes place with light in the range from farinfrared to far ultraviolet (in a range of from 100 nm to 30 μmwavelength), particularly preferably in the range of from near infraredto near ultraviolet (in a range of from 200 nm to 3 μm wavelength), moreparticularly preferably through visible light (in a range of from 400 nmto 800 nm wavelength). This can offer the advantage, with respect to theconventional global heating of the reaction vessel from externally, thatthe thermally insulating wall of the reaction vessel does not need to beovercome, as the energy is transferred directly to the nanoparticles. Aquicker heating of the desired portion of the sample is thus achieved.

The light particularly preferably has a frequency that excites thesurface plasmon resonance of the nanoparticles. The light source canprovide the light pulsed or continuously. The light can, e.g., be a gaslaser, a diode laser or a diode-pumped solid body laser.

The excitation duration, during which the nanoparticles are opticallyexcited in the respectively irradiated volume per cycle, is preferablymore than 1 picosecond, particularly preferably more than 30 picosecondsor 100 picoseconds, more particularly preferably longer than 1nanosecond or 10 nanoseconds. At the same time the duration of effect ispreferably less than 100 ms, particularly preferably less than 10 ms,particularly preferably less than 1 ms, particularly preferably lessthan 500 μs, particularly preferably less than 100 μs, particularlypreferably less than 50 μs and more particularly preferably less than 10μs. If the excitation serves for denaturing, the excitation durationpreferably corresponds to the duration of effect t_(A).

The excitation duration is preferably shorter than it takes on averageuntil the heat arising in the environment of the nanoparticles diffusesthrough the average particle distance, so that on average no significantoverlap of the heat fronts of neighbouring particles takes place. Thetime interval of the excitation is particularly preferably selected sothat the temperature increase, produced by the irradiation, around eachirradiated nanoparticle on average at a distance of 20 nanoparticlediameters, particularly preferably 2 nanoparticle diameters, moreparticularly preferably 1 nanoparticle diameter, falls to less than halfof its maximum. In one embodiment, an irradiation duration that is asshort as possible per volume unit is preferred so that a de-hybridizedDNA single strand can diffuse away from the nanoparticle, during thedenaturing, only less than 100 nm, particularly preferably less than 20nm, particularly preferably less than 10 nm, particularly preferablyless than 5 nm. There is thereby a high probability that thede-hybridized DNA single strand will bind to an oligonucleotide on thesame nanoparticle (“re-hybridization”). This can facilitate anaccelerated method. In one preferred embodiment the concentration of thenanoparticles conjugated to primers is less than 10 nM. The timeinterval of the excitation is thereby particularly preferably between 1ns and 10 μs, particularly preferably between 10 ns and 1 μs and moreparticularly preferably between 15 ns and 300 ns. The time interval ofthe excitation is preferably selected to be not substantially shorterthan 1 ns, as otherwise the time of heating of the DNA double strand isnot sufficient for the two contained single strands to be able tosufficiently separate from each other through diffusion so that they donot immediately hybridize with each other again. If the time interval ofthe excitation serves for the denaturing, it preferably corresponds tot_(A).

The duty factor is the ratio of the duration of effect to the durationof a PCR cycle t_(c). The duty factor is preferably selected to be sogreat that the excitation leads to a sufficient denaturing of the DNAdouble strands through local heating. At the same time the duty factoris preferably selected so that the average temperature increase of thewhole sample is kept sufficiently small so that no interferinginfluences on hybridization, elongation and denaturing arise. The dutyfactor for the irradiated volume is preferably less than 50%,particularly preferably less than 20% and more particularly preferablyless than 1%. The duty factor in the irradiated volume is suitably morethan 10⁻¹², preferably more than 10⁻¹⁰, particularly preferably morethan 10⁻⁹ and more particularly preferably more than 10⁻⁸.

In the sense of the present invention the power density is the opticalpower per area unit of the light impinging into the sample. If it is apulsed light source the peak power is relevant. The power density, withwhich the nanoparticles are excited, is, preferably in at least onepassage of the cycle, particularly preferably in at least 10 passages ofthe cycle, particularly preferably in at least 20 passages of the cycle,particularly preferably in at least 40 passages of the cycle,particularly preferably in at least 80 passages of the cycle and moreparticularly preferably in at least 160 passages of the cycle, more than10 W/mm², particularly preferably more than 50 W/mm², particularlypreferably more than 100 W/mm², particularly preferably more than 200W/mm², particularly preferably more than 300 W/mm² and more particularlypreferably more than 400 W/mm². With this embodiment of the invention itcan be advantageously achieved that the nanoparticles are sufficientlyheated through the excitation.

The power density, with which the nanoparticles are excited, ispreferably in at least one passage of the cycle, particularly preferablyin at least 10 passages of the cycle, particularly preferably in atleast 20 passages of the cycle, particularly preferably in at least 40passages of the cycle, particularly preferably in at least 80 passagesof the cycle and more particularly preferably in at least 160 passagesof the cycle, less than 20,000 kW/mm², preferably less than 10,000kW/mm², particularly preferably less than 5000 kW/mm², particularlypreferably less than 3000 kW/mm², particularly preferably less than 1000kW/mm², particularly preferably less than 500 kW/mm², particularlypreferably less than 300 kW/mm², particularly preferably less than 150kW/mm² and more particularly preferably less than 80 kW/mm². With thisembodiment of the invention, damage to the nanoparticles or the DNAbound thereto can advantageously be counteracted or prevented.

In a further preferred embodiment the energy of the excitation radiationis transferred through the material absorption of the nanoparticles tothese nanoparticles. The light used to excite the nanoparticles can alsocome e.g. from a thermal radiator, e.g. a flashing light. In a furtherpreferred embodiment of the invention the nanoparticles are excitedthrough an electromagnetic alternating field or electromagnetic wavesthat generate eddy currents in the nanoparticles. With a suitable formof the nanoparticles it is also possible to excite the nanoparticleswith ultrasound.

In a preferred embodiment of the invention the nanoparticles areconjugated to oligonucleotides. The nanoparticles form in this waynanoparticle-oligonucleotide conjugates. It can therefore advantageouslybe achieved that oligonucleotides that are parts of the method accordingto the invention are specifically heated through excitation of thenanoparticles without the whole reaction volume having to be heated. Ina particularly preferred embodiment the nanoparticles are conjugated toprimers. More particularly preferably the nanoparticles are conjugatedto the forward and reverse primers of the PCR method. In a preferredembodiment of the invention, forward primers, but no reverse primers,are attached to one class of nanoparticle-oligonucleotide conjugates,and reverse primers, but no forward primers, are attached to a differentclass.

In a further preferred embodiment a class of conjugates of nanoparticlesand oligonucleotides is conjugated both with forward and also reverseprimers. In this embodiment, in the PCR method, starting from theforward primer on a nanoparticle, a new DNA single strand complementaryto the original is written. This new DNA single strand is conjugated tothe nanoparticle, as the new DNA single strand contains the forwardprimer. Directly after writing, the new DNA single strand forms, withthe original, a double strand. In a subsequent denaturing step the newDNA single strand is separated from the original. At an annealingtemperature the new DNA single strand hybridizes with a reverse primer,which is located on the surface of the nanoparticle, so that a loop isproduced. For hybridization with the reverse primer of the samenanoparticle, only a short distance must be covered. For hybridizationwith a reverse primer on a different nanoparticle, a longer distancemust be covered on average with preferred concentrations ofnanoparticles. It can thus be advantageously achieved in this embodimentthat the annealing takes place more quickly and the PCR method can beperformed more quickly.

In a preferred embodiment of the invention the nanoparticles arecombined with the oligonucleotides such that covalent bonds with morethan one thiol are present between oligonucleotides and nanoparticles.PCR buffers generally contain dithiothreitol, which destabilizes thethiol bond between a gold nanoparticle and an oligonucleotide and whichcan lead, in particular with thermal loading such as e.g. during thedenaturing, to oligonucleotides detaching from the nanoparticles.Covalent bonds with more than one thiol between primers andnanoparticles can reduce the detachment of the primers and thus increasethe efficiency of the PCR method.

In a preferred embodiment, counter-sequences are used, which can combinewith such oligonucleotides that have detached from the nanoparticles,with which they were previously combined. Counter-sequences areoligonucleotides. It can arise in the method that oligonucleotidesconjugated with nanoparticles detach from these and thus become free. Ifthese free oligonucleotides are the primers according to the invention,these free primers can bind to the original or complement. Since,however, the free primers are not bound to nanoparticles, the freeprimers cannot be de-hybridized, through excitation of thenanoparticles, from the original or complement. The efficiency andsensitivity of the method thereby fall. The counter-sequences are atleast partially complementary to the free oligonucleotides and bind tothem with sufficient affinity, so that the function of the freeoligonucleotides is limited. The efficiency and sensitivity of themethod can thereby be increased. In a particularly preferred embodimentof the method, already before the addition of the original to thesample, counter-sequences are given to the sample in a sufficient amountin order to block the free primers. At the same time the amount is smallenough so that a sufficiently high number of unblocked primers are stilllocated on the nanoparticles. This is possible if the number of primerson the nanoparticles exceeds the number of free primers.

In a preferred embodiment of the invention, filling molecules areapplied to the nanoparticles. The filling molecules prevent theundesired aggregation of the nanoparticles in the sample. The fillingmolecules thus advantageously serve to stabilize the nanoparticles. Thecharge of the nanoparticles can be modulated through the fillingmolecules. It is hereby possible to adapt the salt concentration foundin the environment of the nanoparticles so that the DNA polymerase cansynthesize as quickly as possible and the method can be performedadvantageously quickly. The filling molecules can consist ofoligonucleotides, but which are not primers and are preferably shorterthan the primers. The filling molecules can also consist, e.g., ofpolymers, such as e.g. polyethylene glycol. In a preferred embodiment,the filling molecules allow the number of primers on the nanoparticlesto be reduced, and instead to use more filling sequences, withoutcausing significant losses in the efficiency of the method.

In a further preferred embodiment of the method, the oligonucleotideshave a spacer sequence as a sub-sequence on the nanoparticles. Thespacer sequence thereby lies on the side of the respectiveoligonucleotide facing towards the nanoparticle. The spacer sequencethus serves as a spacer for the rest of the oligonucleotides. In apreferred embodiment an oligonucleotide contains both a sub-sequencethat has the function of a primer and is described as a primer sequence,and also a sub-sequence that is a spacer sequence. Due to the fact thatthe primer sequences are spaced further apart from the nanoparticlesthrough the spacer sequences, the nucleic acids to be amplified and theDNA polymerases can advantageously have better access to the primersequences. In a preferred embodiment, after being synthesized, thecopies of the original and of the complement remain, via the spacersequences, fixed on the surface of the nanoparticles. In a particularlypreferred embodiment the spacer sequences have detection sequences ofrestriction endonucleases, so that the synthesized copies can beseparated off from the nanoparticles. This is preferably realised afterthe end of the method, but can also arise during the method. It ispossible with the method to produce copies of nucleic acids, which arepresent freely in the sample. In a preferred embodiment of the method,the spacer sequences are at least just as long as the filling molecules,so that the primer sequences are not covered by the filling molecules.

In a preferred embodiment the heat transferred through the excitation ofthe nanoparticles to their environment is sufficient in order tode-hybridize the oligonucleotides on the surface of the nanoparticlesfrom nucleic acids hybridized with the oligonucleotides. In thisembodiment nanoparticles are conjugated to oligonucleotides and at leastsome of these oligonucleotides are hybridized with at least partiallycomplementary nucleic acids. Through the excitation of thenanoparticles, thermal energy is transferred to the surrounding water sothat the temperature of the water around the nanoparticles preferablysuffices in order to denature the oligonucleotides from the nucleicacids combined with them. In a particularly preferred embodiment, thenanoparticles are conjugated to primers. When performing the PCR method,preferably double-stranded PCR products are thereby produced, wherein ineach case at least one single strand of the double-stranded PCR productsis conjugated to a nanoparticle. Through excitation of the nanoparticlesit can advantageously be achieved in this embodiment to produce thedenaturing temperature around the nanoparticles and to perform thedenaturing of the double-stranded PCR products without the wholereaction volume having to be heated. The denaturing can thereby beaccelerated and the PCR method thus takes place more quickly. In afurther preferred embodiment, the annealing temperature and theelongation temperature are also produced through the excitation of thenanoparticles. In comparison with heating the whole sample to theannealing and elongation temperature, it is preferably only necessary totransfer a small amount of energy. Denaturing, annealing and elongationof the PCR method take place particularly preferably without globalheating, but instead exclusively via local heating through excitation ofthe nanoparticles. In this way the method can be carried out without ameans for global heating, so that less apparatus is required to carryout the method.

In a further preferred embodiment the method includes a global heatingstep. The temperature of at least one method step is reached at leastpartially through global heating. In a particularly preferred embodimentthe annealing temperature is reached by global heating of the reactionvolume. More particularly preferably, the reaction volume is maintainedin a predetermined temperature range, in which the annealing takesplace, throughout the whole method and beyond by global heating. Theelongation temperature and the denaturing temperature are therebyreached through excitation of the nanoparticles. The means thatgenerates the global heating can advantageously be kept very simple inits construction, as it must only maintain one predeterminedtemperature.

In a further preferred embodiment the annealing temperature and theelongation temperature are reached by global heating and exclusively thedenaturing is produced through excitation of the nanoparticles. It canadvantageously be achieved that the means that brings about the globalheating has to produce a temperature cycle with only two differenttemperatures and can therefore be kept constructively simple. Theelongation and the annealing usually take place in each case in a narrowtemperature range. On the other hand, only one certain temperature mustbe surpassed for denaturing. Therefore, non-homogeneities in theexcitation of the nanoparticles can be less of a problem for theproduction of the denaturing than when setting the annealing andelongation temperature. Consequently a preferred embodiment, in whichthe excitation of the nanoparticles serves exclusively for denaturing,can be realized technically more simply. In particular this applies tothe particularly preferred case, in which the annealing temperature andthe elongation temperature are very close to each other, e.g. with anannealing temperature of 60° C. and an elongation temperature of 72° C.,so that global heating must only produce a small temperature increase.

In a particularly preferred embodiment the annealing temperature isequal to the elongation temperature. If the annealing temperature isequal to the elongation temperature, only one temperature cycle with twodifferent temperatures is usually necessary to perform the PCR method,whereby the method can be carried out in a simple structure. The melttemperatures of the primers and the DNA polymerase used are particularlypreferably selected so that at the melt temperature the DNA polymeraseused can still synthesize DNA at a sufficient speed. In a particularlypreferred embodiment the elongation temperature, which is equal to theannealing temperature, is reached by global heating and the denaturingis achieved through excitation of the nanoparticles. In this way themeans that brings about the global heating can have a simplerconstructive design, as it only has to maintain one temperature.

In one preferred embodiment, the excitation of only a portion of thenanoparticles takes place at each point in time of the method. For this,e.g. the means serving for exciting the nanoparticles can be designed sothat it excites the nanoparticles present only in a part of the reactionvolume. In a particularly preferred embodiment the nanoparticles areoptically excited and the optics system that guides the light of thelight source into the reaction volume is designed so that light isguided only into one part of the reaction volume. The portion of thenanoparticles that is excited preferably changes in the course of themethod. In other words, a first amount of nanoparticles, which areexcited at a first time point, is not identical to a second amount ofnanoparticles, which are excited at a second time point. In this caseany desired number of nanoparticles can be present in the first amountand any desired number of nanoparticles present in the second amount,provided that the first and second amounts are not identical. One of thetwo aforementioned amounts may, e.g., partially coincide with the otherso that the two amounts form an intersection. One of the amounts can,e.g., be a sub-amount of the other amount, so that one amount containsfewer nanoparticles than the other amount. The two amounts can e.g. alsobe designed so that they do not form an intersection and therefore nonanoparticle is simultaneously present both in the first amount and inthe second amount. One of the two amounts can also be the empty amount(zero), so that e.g. nanoparticles are excited at one time point and nonanoparticles are excited at another time point. In a preferredembodiment the first and the second amounts contain substantially thesame number of nanoparticles. A light source particularly preferablyexcites different portions of the nanoparticles at different times. Inthe embodiment of the method a light source can thereby be used with alower power which just suffices to excite a portion of thenanoparticles. In a particularly preferred embodiment, two or more lightsources are used to excite different portions of the nanoparticles. Itis advantageously possible to excite different portions of thenanoparticles without an optical element being required that guides thelight source onto different parts of the reaction volume.

In a further preferred embodiment of the invention a directed movementof the sample relative to an excitation field takes place so thatnanoparticles in different sub-volumes of the sample are excited atdifferent times. The excitation field is particularly preferably thelight of a laser. In a more particularly preferred embodiment the lightof the light source is guided by an optical element so thatnanoparticles in different sub-volumes of the reaction volume areexcited with the light at different times. The optical element can bearranged to be movable, e.g. the optical element can contain a movablemirror, a spatial modulator or an acousto-optic modulator. The lightsource itself can also be arranged to be movable. The movement of thesample can also be realized so that the reaction vessel containing thesample is moved. In a particularly preferred embodiment both the lightbeam and also the reaction vessel are moved. In a further preferredembodiment the sample is moved in the reaction volume, so that the lightof the light source detects different sub-volumes of the sample atdifferent times. This can be achieved e.g. by the sample being stirredin the reaction volume, e.g. by a magnetic stirrer. The reaction volumecan e.g. be in an elongated form, e.g. a duct or a tube. The sample cane.g. be moved through a duct, wherein the sample passes through a lightbeam at one or more positions. A sample particularly preferably flowsthrough a duct and passes n positions, at each of which a light beam isdirected onto the sample in the duct, wherein through the linear flow ofthe sample through the n light beams a PCR method with n cycles iscarried out. n is thereby preferably greater than 80. The method can beadvantageously carried out with a small number of movable parts. Byusing a duct, a miniaturisation, e.g. in the sense of a lab-on-chip, isalso possible. The denaturing is preferably produced through the lightbeam, while the elongation and annealing temperature are produced byglobal heating. The elongation temperature is particularly preferablyequal to the annealing temperature so that only one temperature has tobe maintained by global heating. In this way the method according to theinvention can advantageously be carried out with a low level ofresources.

In a preferred embodiment a DNA polymerase that is thermolabile is usedin the method. If the excitation of the nanoparticles is used fordenaturing it is possible to avoid the whole reaction volume beingexposed to high temperatures. It is instead possible to bring only thedirect environment of the nanoparticles to the denaturing temperature.The DNA polymerases that are not located in this direct environment arenot therefore exposed to high temperatures. It is thereby possible toalso use DNA polymerases that are not heat-stable, thus thermolabile.Through the inclusion of the thermolabile DNA polymerases, therefore, alarger selection of DNA polymerases is available for the methodaccording to the invention. Through the greater selection of DNApolymerases the reaction conditions can be changed to a greater extentand at the same time a sufficient functioning of the respective DNApolymerase can be maintained. In order that the nucleic acids to beamplified can bind to the negatively charged oligonucleotides on thenanoparticles, it may be necessary to use substances—in particularsalts—in the sample in concentrations that negatively influence thefunctioning of a thermostable DNA polymerase, which reduces theefficiency of the method. The greater selection of DNA polymerases—inparticular those having a high tolerance for salts—can lead to anincrease in the efficiency of the method being achieved. Part of thelarger selection of DNA polymerases are small DNA polymerases such ase.g. the Klenow fragment and Phi29. In the proximity of thenanoparticles, large thermostable DNA polymerases can experience asteric hindrance through the applied and possibly already elongatedprimers. It can thereby arise that the DNA polymerase does not arrive atthe nucleic acid to be copied, or the DNA polymerase breaks off beforeit has synthesized a complete copy of the original or complement, whichsignifies a reduction in the efficiency of the method. The greaterselection of DNA polymerases thus facilitates an increase in theefficiency of the method. Through the larger selection of DNApolymerases, enzymes with lower production costs are also advantageouslyavailable. The DNA polymerases that are not located in the directenvironment of the nanoparticles experience a lower heat-relateddeactivation. It is thereby advantageously possible to use a smalleramount of DNA polymerase in the method.

In a preferred embodiment of the invention, both soluble primers andalso primers on nanoparticles are present in the reaction volume. Thesoluble primers are not conjugated to nanoparticles, but instead aredissolved in the sample. The soluble primers have preferably smallerdimensions than the nanoparticle-primer conjugates and can be present ina higher concentration than the nanoparticle-primer conjugates.Therefore, the soluble primers can have better and quicker access tolong, double-stranded nucleic acids such as e.g. genomic DNA. In aparticularly preferred embodiment, in a first step of the method thelong, double-stranded nucleic acids are denatured by global heating ofthe whole reaction volume, after which the dissolved primers hybridizewith the nucleic acids. The PCR method thereby initially takes place inone or more cycles with global heating, the DNA polymerase therebysynthesizes the desired, short copies of the long, double-strandednucleic acids. After this, the PCR method is continued, wherein localheating is also used through excitation of the nanoparticles.

In a preferred embodiment of the invention the particle diffusion of thenanoparticle-primer conjugates can be reinforced by optical fields. Bymeans of optic eddy fields (according to Silvia Albaladejo et al., NanoLetters, 2009, Volume 9, Issue 10, pages 3527 to 3531, of which therelated content is part of the present disclosure through referencethereto), with which the nanoparticles are excited, or through opticforces (according to Arthur Ashkin et al., Proc. Natl. Acad. Sci., 1997,Volume 94, Issue 10, pages 4853 to 4860, of which the related content ispart of the present disclosure through reference thereto), which can beexerted on the nanoparticles, the nanoparticle diffusion can beincreased. It can advantageously be achieved that, with a givennanoparticle concentration, a more rapid hybridization of the nucleicacids to be amplified takes place with the primers on the nanoparticles.This can be used to accelerate the method according to the invention.

In one embodiment of the invention the concentration of the products ofthe amplification reaction is determined by test probes. Test probes arenanoparticles which have, on their surface, oligonucleotides with testsequences. In a preferred embodiment of the method the oligonucleotidesof the test probes have a spacer sequence as a sub-sequence. The spacersequence is thereby on the side, facing towards the nanoparticle, of therespective oligonucleotide. The spacer sequence thus serves as a spacerfor the rest of the oligonucleotide. In a preferred embodiment anoligonucleotide of the test probes contains both a sub-sequence that isdescribed as a test sequence and also a sub-sequence that is a spacersequence. In a preferred embodiment, filling molecules are applied tothe test probes. The test sequences can hybridize with products of theamplification reaction. The test sequences are thereby preferably atleast partially complementary to the products of the amplificationreaction. In a preferred embodiment first nanoparticles are conjugatedto forward primers. In the presence of the original and a DNA polymerasethe forward primers are extended so that complements are produced, whichare bound via the forward primers to the first nanoparticles. Acomplement consists of the forward primer and an extension sequence,which arises through the extension of the forward primer. Particularlypreferably, using free and/or nanoparticle-bound reverse primers, a PCRmethod is carried out so that in an exponential amplification a largenumber of copies of the original and nanoparticle-bound complements arepreferably produced. More particularly preferably, the firstnanoparticles have, on their surface, both forward primers and alsoreverse primers. In an optional intermediate step, the originals andpossibly copies thereof are denatured from the complements through localor global heating. The first nanoparticles are then brought togetherwith test probes if this has not already taken place. The test sequencesof the test probes are complementary to the extension sequences, suchthat the test probes can bind via test sequences to the extended forwardprimers on the first nanoparticles. Under suitable reaction conditionsthe combination of the first nanoparticles with the test probes comesabout to the same extent as that in which nanoparticle-bound complementsare also present. This means that, if no extension sequences areproduced, no combination of test probes and first nanoparticles arises.

The reaction conditions of the amplification according to the inventionand the detection through test probes are particularly preferablyselected so that the degree of combination of first nanoparticles withtest probes allows conclusions to be drawn concerning the concentrationof the original that was present in the sample before the amplification.Through the combination of the first nanoparticles with the test probesa measureable change can arise, e.g. a redshift or broadening of theplasmon resonance in the extinction spectrum. In a more particularlypreferred embodiment the measurable change that arises through thecombination of test probes and first nanoparticles is proportional tothe concentration of the original in the sample before theamplification. Concentration detection can thus advantageously berealized with simple means.

In a further preferred embodiment the method includes forward primers,which are conjugated to first nanoparticles, and free and/ornanoparticle-bound reverse primers. It is particularly preferred thatthe first nanoparticles have both forward primers and also reverseprimers on their surface. In a first step, the forward primers areextended in the presence of the original through a DNA polymerase tonanoparticle-bound complements. In a second step, starting from thereverse primers, which bind to the nanoparticle-bound complement, copiesof the original are synthesized. Subsequently the first nanoparticlesare brought together with test probes if this has not already takenplace. The test sequences in this embodiment are complementary to theforward primers. If the forward primers have not been extended, the testprobes can bind well to the first nanoparticles. If the forward primershave been extended, the binding of test sequences to forward primers ishindered by steric hindrance. If a newly synthesized copy of theoriginal is hybridized with the extended forward primer, the binding ofthe test sequence to the extended forward primer is prevented. In thisway, the degree of combination between first nanoparticles and testprobes decreases to the same extent as that in which products of theamplification reaction, i.e. complements and copies of the original,were synthesized. With a suitable selection of the reaction conditions aconcentration detection of the original in the sample can be carriedout, so that a measurable change is smaller, the more original that waspresent in the sample before the amplification. The measurable changecan thereby be, e.g., a redshift or broadening of the plasmon resonancein the extinction spectrum. A simple test can advantageously be designedwhich allows the determination of concentrations of specific nucleicacids.

Through the invention it is possible to provide an improved method forthe amplification of nucleic acids.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 shows in a schematic illustration nanoparticles that areconjugated with filling molecules, spacer sequences, abasicmodifications and primer sequences;

FIG. 2 shows in a schematic illustration a structure for carrying outthe method according to the invention with a laser, a two-dimensionalmirror scanner and a sample;

FIG. 3 shows in a schematic illustration a further structure forcarrying out the method according to the invention with a laser, atwo-dimensional mirror scanner and sample tubes in a water bath;

FIG. 4 shows the idealized temperature profile of a conventional PCR(dotted line);

FIG. 5 shows the amplification factor N_(k)/N_(o) as a function of thetime for different parameters; and

FIG. 6 shows in four diagrams the results of amplification reactionswith different cycle times and numbers of cycles.

DETAILED DESCRIPTION OF THE INVENTION BY REFERENCE TO A PLURALITY OFEXEMPLARY EMBODIMENTS

In known PCR methods for the amplification of a short nucleic acid (e.g.with fewer than 300 base pairs), which work with tempering by means ofthermocyclers, the process duration is generally limited by thetempering time, which accounts for a large part of the cycle duration.In order to achieve a process duration that is as short as possible, itis endeavoured in such cases, with respect to the yield g_(h) (the index“h” points towards this conventional case) per passage of the cycle, toarrive close to the theoretical threshold of 100%, in order to achievethe desired result with as few cycles as possible. According to thefindings of the inventors, however, in methods with shorter temperingtimes, e.g. in methods that work with local heating by means ofnanoparticles, a maximization of the yield g is no longer necessarilythe best strategy. Instead, here, taking into account a reduced yield, ashortening of the cycle duration that outweighs the disadvantages of thelower yield can be achieved, such that overall, despite lower yield,shortening of the process duration results.

Without adhering to a certain theory, it is firstly necessary to observethe characteristic time constants required by different processes duringthe PCR and a simple mathematical model is to be formulated.

Firstly, a conventional PCR method is assumed, which is carried out in acustomary thermocycler, e.g. with a Peltier element or an air stream inorder to temper the reaction volume (usually 5 to 50 microlitres) fromexternally. Such customary thermocyclers typically achieve heating andcooling rates of approximately 5 K/s, even if the average temperingspeed may be significantly lower. This means that the process of heatinga sample from an annealing temperature of 60° C. to a denaturingtemperature of 95° C. and then cooling it again to the annealingtemperature can require at least approximately:

${{2 \cdot 35}{^\circ}\; {C.\text{/}}\left( {5\frac{\;^{{^\circ}}C.}{s}} \right)} = {14\mspace{14mu} {s.}}$

Added to this is the fact that, with methods used thus far, thethermalization of the sample volume can additionally take a few secondsuntil approximately the same temperature prevails everywhere in thesample, such as on the heated or cooled vessel walls. Consequently, thetotal tempering time t_(t) per cycle in conventional protocols istypically more than 14 s.

For a PCR, the annealing and elongation times are also important. Theannealing time in the case of sufficiently high primer concentrations(e.g. more than 300 nM) under suitable conditions in the prior art isfrequently a few seconds until a primer is hybridized to the majority(>90%) of the targets. For example an annealing time of 1 s can also berealized.

The time required by the polymerase for elongation of the primersdepends upon the length of the amplicon and the write speed of thepolymerase used. In order to elongate, for example, 80 base pairs, theelongation under suitable conditions, in the case of a polymerase witheffective write speed of 100 BP/s, takes approximately 0.8 s.

The hybridization time and the elongation time together are referred tobelow as the required productive time t_(ph). In the above example, therequired productive time for a short amplicon is for example t_(ph)=2 s,if one second is assumed for annealing and a further second forelongation.

The duration of a PCR cycle t_(ch) in the abovementioned example is thesum of the tempering time t_(th) and the required productive timet_(ph), i.e.:

t _(ch) =t _(th) +t _(ph)  (3)

If any dwell time at the denaturing temperature is disregarded, as itcan be selected to be very short, e.g. it can be shorter than onesecond.

If the tempering time of approximately 14 s is compared with therequired productive time of approximately 2 s in the above example, itcan be seen that, in a conventional thermocycler for short nucleicacids, the following inequalities typically apply: t_(th)>>t_(ph) andt_(ch)≈t_(th). This means that the tempering time, i.e. the heating andcooling times, thus the time taken to bring the sample from theannealing temperature to the denaturing temperature and cool it backdown steadily to the annealing temperature, generally determines theduration of each cycle and thus also the total duration of the PCR.

If the number of copies N₀ of the template is to be increased to N_(k)copies with the PCR, this can—as already explained above—be achievedwith a number k of temperature cycles, wherein k=log_((1+gh))(N_(k)/N₀)if the average yield in each cycle is g_(h). It is assumed once againfor simplification purposes that the yield per cycle remains constantduring the PCR. If f_(c0) cycles are carried out per time unit (withf_(ch)=1/t_(ch), the number of the copies N_(k) after a time t can begiven by:

N _(k) =N ₀(1+g _(h))^(fc) ^(h) ^(t)  (4)

wherein g_(h)=0 . . . 100%. The process duration T of the whole PCR canbe given by the cycle duration t_(ch) multiplied by the necessary numberof cycles k:

$\begin{matrix}{T = {{t_{c_{h}} \cdot k} = {t_{c_{h}} \cdot {{\log_{({1 + g_{h}})}\left( \frac{N}{N_{0}} \right)}.}}}} & (5)\end{matrix}$

For example, an amplification by the factor N_(k)/N₀=10¹², depending onthe value of g_(h), can require the times shown in Table 1.

TABLE 1 Preferred PCR durations T in units of the cycle duration t_(ch)to the 10¹² times amplification of a target. g_(h) T[t_(ch)] 0.4 82 0.659 0.80 47 1.00 40

It follows from this that in the case of a conventional PCR, whereint_(th)>>t_(ph) and t_(ch)≈t_(t)h, a short process duration can beachieved by the yield per cycle being maximized, g_(h) thus being closeto 100%. In this case, the number of copies N_(k) with the time can begiven by:

N _(k) =N ₀(1+1)^(fc) ^(h) ^(t) =N ₀·2^(fc) ^(h) ^(t),  (6)

i.e.: for each cycle, the number of copies thus far can have added to itthe same number (i.e. being doubled for each cycle). The shortestpossible PCR duration T_(min) for an amplification by the amplificationfactor N_(k)/N₀ can then be given by:

$\begin{matrix}{T_{\min} = {{t_{c} \cdot k} = {t_{c} \cdot {{\log_{2}\left( \frac{N_{k}}{N_{0}} \right)}.}}}} & (7)\end{matrix}$

A different situation can emerge if the tempering times no longerdetermine the cycle duration. This case includes in particular also thesub-case that heating and cooling steps, including the thermalization,are negligibly short, i.e. if the following inequalities apply:t_(t)<<t_(p) and t_(c)≈t_(p).

Example 1

The effect of shortening the cycle duration is to be examined below. Thecycle duration in this example is described as t_(ci) (the optionalindex “i” is used below to emphasize the solution according to theinvention for the parameters, which describes a PCR with shortened cycledurations), wherein the example cycle duration t_(ci) has beenshortened, with respect to the cycle duration t_(ch) in the conventionalcase, by a shortening factor x with

xε

^(>1)

so that the following applies:

$t_{c_{i}} = {\frac{t_{c_{h}}}{x}.}$

i.e.: the new cycle frequency f_(ci)=x·f_(ch) can be calculated from thecycle frequency f_(c) of the conventional case. The yield in thisexample is described with g_(i). The example yield can be equal to theyield in the conventional case (g_(i)=g_(h)), but it can also be smallerthan this (g_(i)<g_(h)). If there is a reduction in the yield per cycle,this can be described by an efficiency loss factor y, wherein:

$g_{i} = {\frac{g_{h}}{y}.}$

It follows that in this example:

$\begin{matrix}{N_{i} = {{N_{0}\left( {1 + \frac{g_{h}}{y}} \right)}^{f_{c_{h} \cdot x \cdot t}} = {{N_{0}\left( {1 - g_{i}} \right)}^{f_{c_{i}} \cdot t} = {{N_{0}\left( {1 - g_{i}} \right)}^{f_{c_{h}} \cdot x \cdot t}.}}}} & (8)\end{matrix}$

The process duration T_(i) of the whole PCR in this example istherefore:

$\begin{matrix}{{T_{i} = {\frac{t_{c_{h}}}{x} \cdot {\log_{({1 + g_{i}})}\left( \frac{N_{i}}{N_{0}} \right)}}},} & (9)\end{matrix}$

for which the fact that preferably

$f_{c_{h}} = {\frac{1}{t_{c_{h}}}.}$

has one again been utilized.

A shortening of the process duration in comparison with the conventionalcase can be achieved both if g_(i)=g_(h) and also if gi<g_(h), providedthat the disadvantage of the lower yield is outweighed by the advantageof shortening of the cycle duration.

If for example amplification by the factor N₁/N₀=10¹² is assumed,according to Equation (9) the following values can be given for theprocess duration in units of t_(ch) as a function of the selection ofthe values for g_(i) and x.

TABLE 2 PCR durations T of a conventional PCR and preferred PCRdurations T_(i) in units of the conventional cycle duration t_(ch) to10¹² times amplification of a target. Conventional PCR duration χ T withx = 1 1.11 1.25 1.33 1.67 2.00 4.00 10.00 g_(i) 0.05 566 *  510 *  453*  425 *  340 *  283 *  142 *  57 * 0.10 290 *  261 *  232 *  217 * 174 *  145 *   72 * 29  0.15 198 *  178 *  158 *  148 *  119 *   99 *  49 * 20  0.20 152 *  136 *  121 *  114 *   91 *   76 *  38+ 15  0.25124 *  111 *  99 * 93 *  74 *   62 * 31 12  0.30 105 *  95 * 84 * 79 * 63 *   53 * 26 11  0.35 92 * 83 * 74 * 69 *  55 *   46 * 23 9 0.40 82 *74 * 66 * 62 *  49 *   41 * 21 8 0.45 74 * 67 * 59 * 56 *  45 *  37+ 197 0.50 68 * 61 * 55 * 51 *  41 * 34 17 7 0.55 63 * 57 * 50 * 47 *  38+ 32 16 6 0.60 59 * 53 * 47 * 44 * 35  29 15 6 0.65 55 * 50 * 44 * 41 *33  28 14 6 0.70 52 * 47 * 42 * 39+  31  26 13 5 0.75 49 * 44 * 39+ 37   30  25 12 5 0.80 47 * 42 * 38   35   28  24 12 5 0.85 45 * 40 *36   34   27  22 11 4 0.90 43 * 39   34   32   26  22 11 4 0.95 41 *37   33   31   25  21 10 4 1.00 40 * 36   32   30   24  20 10 4 Thevalues marked with * illustrate the range in a theoretical observationof the combinations of g_(i) and x, for which no acceleration ariseswith respect to a conventional PCR with g_(h) ≈ 100%.

Example 2

This example is based on Example 1 and includes the case in which thecycle duration t_(ci) according to the invention is preferably selectedto be shorter than the conventional cycle duration t_(ch), butfurthermore in such a way that the yield per cycle can remainapproximately the same as in the case of the selection of the cycleduration to date t_(ch), i.e. g_(i) √g_(h) (this can, e.g. make itnecessary for the annealing and the elongation to continue in each cycleto run with approximately the same efficiency as when the cycle durationthus far t_(ch) is selected). In other words, here the efficiency lossfactor y=1, as according to definition in this example no efficiencyloss arises.

In this case the number of cycles necessary for a desired amplificationcan then remain constant, and the duration of each cycle can beshortened by the factor x and the process duration according to theinvention can be shortened corresponding to T_(i)=T/x. In other words:with the example values indicated in Table 2 the PCR duration of ahypothetical conventional PCR T can be read within the scope of thistheoretical observation in the second column. The process duration for aPCR according to the invention with g_(0i); =g₀ can then be read in thesame line as the conventional comparative value.

In an example realization of these examples, the cycle duration isselected so that it continues to be greater than the required productivetime t_(ci)−t_(ti)>>t_(pi), so that, e.g. approximately g_(i)=g_(h)≈100%is reached.

Example 3

This example is also based on Example 1. However, it is now assumed thatthe shortening of the example cycle duration t_(ci) in comparison withthe conventional cycle duration t_(ch) leads to a reduction in theaverage yield per cycle g_(i) in comparison with the average yield thusfar g_(h)

$\left( {{{i.e.\mspace{14mu} {the}}\mspace{20mu} {efficiency}\mspace{14mu} {loss}\mspace{14mu} {factor}} = {y = {\frac{g_{h}}{g_{i}} > 1}}} \right).$

As further assumed, this decrease in the yield per cycle, which canresult from the shortening of the cycle duration by factor x, but can bemore than compensated through more temperature cycles (which can becarried out more quickly by the factor

$\left. {x = \frac{t_{c_{h}}}{t_{c_{i}}}} \right),$

i.e. the increase in the amplicon concentration per time unit isnevertheless higher (wherein the time unit under observation ispreferably to be selected to be very much longer than t_(ch)).

A decrease in the average yield per cycle can be realised, e.g., by thecycle duration becoming even shorter than the required productive time,i.e. t_(ci)<t_(pi), wherein t_(pi)=t_(ph) remains, so that the yield percycle is g_(h)>>100% (e.g. because only few copies of the template canhybridize in the time with a primer and/or the polymerase cannot, in thetime, elongate all the primers or the denaturing does not take placecompletely, since, e.g., the duration of effect is so short that the DNAdouble strand cannot sufficiently unravel.

Example 3a

It is assumed in this example that the following relationship appliesfor the yield:

$\begin{matrix}{g_{h} \geq g_{i} \geq {\frac{g_{h}}{x}.}} & (10)\end{matrix}$

In other words, the average yield per cycle increases in this embodimentpreferably maximum linearly with the shortening x of the cycle duration,whereby this can arise for example if the cycle duration no longersuffices for a large part of the template DNA to be able to hybridizewith a primer (i.e. the efficiency loss factor is here 1<y≤x). Thedecrease in the yield per cycle, which is maximum factor x, can therebybe more than compensated by x times more cycles per time unit. In thiscase it can be written as follows:

$\begin{matrix}{{N_{i} \geq {N_{0}\left( {1 + \frac{g_{h}}{x}} \right)}^{f_{c_{h}} \cdot x \cdot t}} = {{N_{0}\left( \underset{\underset{:=\alpha}{}}{\left( {1 + \frac{g_{h}}{x}} \right)^{x}} \right)}^{f_{c_{h}} \cdot t} = {N_{0} \cdot {\alpha^{f_{c_{h}} \cdot t}.}}}} & (11)\end{matrix}$

In this case the basis of the exponential function a can be greater thanin a conventional PCR, where the basis of the exponential function canbe according to Equation (4) (1+g_(h)) and, in the best case scenario,is equal to two. This is summarized in the following table, whichcontains values for (1+g_(h)) and also for α:

TABLE 3 Values for α in comparison with a hypothetical basis, thus far,of the exponential function (1 + g_(h)). Conven- tional (1 + g_(h)) 1.111.25 1.33 1.67 2.00 4.00 10.00 g_(h) 0.40 1.40 1.41 1.41 1.42 1.43 1.441.46 1.48 0.60 1.60 1.62 1.63 1.64 1.67 1.69 1.75 1.79 0.80 1.80 1.831.86 1.87 1.92 1.96 2.07 2.16 1.00 2.00 2.04 2.08 2.11 2.19 2.25 2.442.59

This means that the amplification taking place per time unit can begreater than conventionally, provided that g₀>0 and Equation 10 isfulfilled. The inventors therefore refer to the process according to theinvention also as “super-amplification”.

The time required by a PCR according to the invention in this embodimentis given if Equation 9 for the PCR duration is re-written to:

$\begin{matrix}{T_{i} \leq {\frac{t_{c_{h}}}{x} \cdot {{\log_{({1 + {g_{0}/x}})}\left( \frac{N}{N_{0}} \right)}.}}} & (12)\end{matrix}$

In other words: In the example of Table 2 the PCR duration of ahypothetical conventional PCR can be read in the second column. Incomparison with a conventional comparative value, the process durationaccording to the invention can then be read in an entry with valueswithout * or + in the same line or above, depending on which valuecombination of g_(i) and x is realised.

A particularly interesting variant of this embodiment results forconventional PCRs, wherein the yield per cycle g₀≈100% (lowermost linein Table 3).

In this case, α in Equation 11 can be approximately re-written as

$\alpha = {\left( {1 + \frac{1}{x}} \right)^{x}.}$

PIC. It can also be preferably achieved that x becomes very high, sothat approximately the threshold formation

${\lim_{x\rightarrow\infty}\left( {1 + \frac{1}{x}} \right)^{x}} = e$

is admissible (e≈2.71828 . . . ), so that the value for N_(i) can beapproximated from Equation 11 as:

N _(i) ≈N ₀ ·e ^(fc) ^(h) ^(t)  (13)

It is shown here, in comparison with Equation 6, that the time-basedamplification can no longer take place with

2^(f_(c_(h)) ⋅ t),

but instead with

e^(f_(c_(h)) ⋅ t),

i.e. the basis of the exponential function can be greater.

From Equation 13, the process duration for the case in which x is veryhigh, can be approximately estimated as

$\begin{matrix}{{T_{i} \approx {{\ln \left( \frac{N_{i}}{N_{0}} \right)}t_{c_{h}}}},} & (14)\end{matrix}$

for which the fact that f_(ch)=1/t_(ch) has again been utilized. Inother words, in this case the process duration can go hand in hand withthe natural logarithm of the amplification factor.

Example 3b

This example is also based on Example 1. Shorter temperature cycles canalso be used in this embodiment. However, in this embodiment theshortening according to the invention of the cycle duration t_(ci), withrespect to the cycle duration t_(ch) thus far, can lead to a reductionin the yield per cycle g_(i) with respect to the yield g_(h) thus far,so that the following can apply:

$\begin{matrix}{{\frac{g_{h}}{x} > g_{i}},} & (15)\end{matrix}$

This means that the yield per cycle in this embodiment can decrease morethan linearly with the shortening x of the cycle duration (i.e. theefficiency loss factor is here y>x). Also in this case, the decrease inthe yield per cycle can be preferably overcompensated by more cycles,which are carried out more quickly than conventionally by the shorteningfactor x under suitable conditions.

In the example of Table 2 the hypothetical process duration of aconventional PCR can be read in the lowermost entry of the second columnfor g_(h)≈100% (in this case therefore: the value 40). The processduration in this embodiment of the invention can then be read in theentries, of which the values are marked with a +, provided that thisvalue combination of g_(i) and x can be realized.

FIG. 1 shows an exemplary embodiment of the method according to theinvention for the amplification of nucleic acids 1, which is carried outas a PCR. First nanoparticles 3 are contained in a reaction volume 2.The first nanoparticles 3 have oligonucleotides 4 at their surface, asshown in FIG. 1a . One class of oligonucleotides 4 contain, in each caseas a sub-sequence, a primer sequence 5 with the sequence A and, as afurther, optional sub-sequence, a spacer sequence 6 S and an optionalabasic modification 7 between the primer sequence 5 A and spacersequence 6 S. The primer sequence 5 thereby serves as a forward primer8. The spacer sequence 6 S is used to keep the primer sequence 5 farenough away from the surface of the nanoparticles 9 so that a nucleicacid 1 to be amplified can bind with better efficiency to the primersequence 5 and a DNA polymerase 11 can find better access to the primersequence 5. The abasic modification 7 prevents the spacer sequence beingoverwritten by the polymerase 11. The oligonucleotides 4 with the primersequence 5 A are, e.g., fixed with a thiol bound to the surface of thefirst nanoparticles 3, so that the 3′-end faces away from the firstnanoparticle 3. Optionally, a further class of oligonucleotides 4 can belocated on the surface of the first nanoparticles 3, these are thefilling molecules 10 F. With the filling molecules 10 the charge of thenanoparticles 9 can be modulated so that undesired aggregations of thenanoparticles 9 do not arise. In addition the filling molecules 10 canincrease the distance of the primer sequences 5 from each other on thesurface of the nanoparticles 9, so that the nucleic acids 1 to beamplified and the DNA polymerase 11 have better access to the primersequences 5. This can increase the efficiency of the method. The spacersequence 6 is thereby preferably at least as long as the fillingmolecules 10, so that the primer sequences 5 advantageously project outof the filling molecules 10.

In the reaction volume 2 there is a liquid sample 12, which contains thefirst nanoparticles 3 of FIG. 1a with the primer sequences 5, spacersequences 6, abasic modification 7 and filling molecules 10, and whichalso has dNTPs and DNA polymerase 11. A nucleic acid 1 to be detectedcan be present in the sample 12. In this exemplary embodiment thenucleic acid 1 to be detected is a DNA single strand, which is alsodescribed as an original 13 or amplicon, and has a sub-sequence A′ andalso a sub-sequence B′. The original 13 can also have furthersub-sequences, e.g. as overhangs at the 5′-end or 3′-end or between thetwo sub-sequences A′ and B′. In FIG. 1b , the original 13 with itssub-sequence A′ binds to the primer sequence 5 A on the surface of thefirst nanoparticles 3. It is shown in FIG. 1c that a DNA polymerase 11binds to the original 13 and the primer sequence 5 A hybridized with theoriginal 13. Then, the DNA polymerase 11 synthesizes, in an elongationstep shown in FIG. 1d , starting from the 3′-end of the primer sequence5 A, a nucleic acid 1 that is complementary to the original 13 and isreferred to as a complement 14 and is combined with the spacer sequence6 on the surface of the first nanoparticle 3. In FIG. 1e , the firstnanoparticle 3 is then irradiated with light, which is absorbed by thefirst nanoparticle 3 due to its plasmonic or material properties and isconverted into heat. The heat is emitted to the environment of the firstnanoparticle 3 and, in the area of the original 13 and the newlysynthesized complement 14 hybridized with it, the heat is sufficient forthe original 13 to denature from the complement 14. The original 13 isnow free again, as shown in FIG. 1f , so that it can bind to a furtherprimer sequence 5 and further nanoparticle-bound complements 14 can besynthesized in further cycles of the method. This produces a linearincrease in the concentration of the complements 14 with an increasingnumber of cycles.

In one embodiment of the method, after the extension of the primersequence 5 on the surface 4 of the first nanoparticles 3, wherein ananoparticle-bound complement 14 is produced, a free reverse primer 15is used, which binds to the 3′-end of the complement. It is shown inFIG. 1g that the already synthesized complement 14 with thesub-sequences A and B, which is combined via a spacer sequence 6 and anabasic modification 7 on the surface of the first nanoparticle 3,hybridizes with a reverse primer 15 B′ that was previously free in thesample 12. The primer 8 has the sequence B′ and is combined with thesub-sequence B of the complement 14. Starting from the primer 8 with thesequence B′, the DNA polymerase synthesizes a copy of the original 13.The synthesis takes place only up to the abasic modification 7, as thiscannot be overwritten by the polymerase 11. It is also shown in FIG. 1gthat the original 13 has bound to a further primer sequence 5 A on thesurface of the first nanoparticle 3 and a DNA polymerase 11 startingfrom the primer sequence 5 A synthesizes a further complement 14. Theoriginal 13, the copy of the original 13 and the two complements 14combined with the first nanoparticle are shown in FIG. 1h . A subsequentdenaturing through excitation of the first nanoparticles 3 leads to theoriginal 13 and its copy becoming free. Both the original 13 and alsoits copy can thereby serve in subsequent steps of the method as atemplate for amplification. After a waiting period, which is possiblynecessary for the hybridization of the original 13 and copies of theoriginal 13 with primer sequences 5 A on the first nanoparticles 3 andfree primers 8 B′ with primer sequences 5 already elongated on the firstnanoparticles 3, the next cycle of the method can be carried out with afurther excitation of the first nanoparticles 3. The cycle is preferablyrepeated until a sufficient number of extended primer sequences 5 arelocated on the first nanoparticles 3 and/or a sufficient number ofcopies of the original 13 are located in the sample 12, in order to beable to carry out a detection of the completed amplification or thepresence of the original 13 in the sample 12. Through a free primer 8B′, as shown in FIGS. 1g and 1h , an exponential amplification of theoriginal 13 is possible. In FIGS. 1a to 1f , without this free primer 8,however, only a linear amplification of the nanoparticle-boundcomplement 14 can be achieved.

FIG. 2 shows a structure that is suited for carrying out the methodaccording to the invention. The structure contains a light source, whichis implemented in this example as a laser 16, and a two-dimensionalmirror scanner 17, which can guide light from the laser 16 to the sample12. The two-dimensional mirror scanner 17 can thereby deflect the laserbeam in two dimensions. The denaturing in the sample 12 takes place inthis structure in that a laser beam is focussed on a part of the sample12. In the course of the method the laser beam is deflected so that itimpinges on different parts of the sample 12. In the example shown inFIG. 2, the laser beam is deflected by the mirror scanner 19 in such away that the laser beam travels linearly over the reaction volume 2, inwhich the sample 12 is located. The path covered by the laser beam isshown in dotted lines in FIG. 3 in the sample 12. Due to the fact thatat each time point of the method only parts of the sample 12 areexcited, lasers 16 with a lower power can be used. As excitations ofless than a microsecond suffice in order to denature DNA with the aid ofoptothermally heated nanoparticles 9, in the case of typical focusdiameters of a laser 16 from approximately 10 to 100 μm, a laser beamwith a speed of approximately 10 to 100 m/s can scan the sample 12 andthereby lead to a denaturing of the DNA at each point over which thelaser beam travels. This facilitates a very rapid scanning also of largesample volumes. The complete scanning of a surface area of 1 cm² takesonly 128 ms, e.g. with a focus diameter of 78 μm and 128 lines at a linedistance of 78 μm and a line length of 1 cm, with a speed of thescanning laser beam of 10 m/s. If the volume has e.g. a depth of 10 mm,a volume of 1 ml can be processed (for this it must of course beensured, inter alia, that the intensity of the excitation issufficiently high over the whole depth). This is advantageouslysubstantially shorter than would generally be required by a denaturingstep through global heating. With optical elements such as e.g. a mirrorscanner 17 shown in FIG. 2, and so-called F theta lenses, a goodhomogeneity of the focus quality and size can be achieved over the wholescanned sample 12. Alternatively to a continuously emitting laser 16, apulsed laser 16 or a thermal radiator can also be used.

In the embodiment of the method shown in FIG. 1, first nanoparticles 3of gold with a diameter of 60 nm are functionalized witholigonucleotides 4 ID1 (according to J. Hurst et al., Anal. Chem.,78(24), 8313-8318, 2006, the related content of which is part of thepresent disclosure by virtue of reference thereto). Afterfunctionalization and 6 washing steps, the first nanoparticles 3 arepresent in a concentration of 200 pM in a PBS buffer (5 mM PBS, 10 mMNaCl, 0.01% Tween 20, pH 7.5). The amplification reaction is carried outin a total volume of 10 μl in 100 μl sample tubes 18 (2 μl Apta TaqMastermix 5× with MgCl2 (obtained from Roche), 1 μl NaCl 450 mM, 1 μlMgCl₂ 90 mM, 1 μl Tween 20 1%, 2 μl water, 1 μl of the functionalizedfirst nanoparticles 200 pM, 1 μl oligonucleotide 4 ID2 5 μM as adissolved reverse primer and 1 μl oligonucleotide ID3 as original 13 tobe amplified). The concentration, to be determined, of the original 13in the total volume of 10 μl, e.g. 0.1 fM of the oligonucleotide ID3dissolved in water with 100 nM oligonucleotide 4 ID4 (oligonucleotideID4 hereby serves for the saturation of surfaces, e.g. during themaintenance of the original 13 before the reaction.) As shown in FIG. 3,the sample tubes 18 are brought in a glass cuvette 19 in a water bath 20to a temperature of 64° C., which constitutes both the annealingtemperature and the elongation temperature. The water bath 20 serves,besides tempering, also for improved introduction of the laser 16 intothe non-planar surface of the sample tubes 18. The water in the waterbath 20 allows the refractive index difference between the outside andthe inside of the sample tubes 18, filled with PCR reaction mix, to bereduced and to therefore prevent a refraction of the laser beam andhence a negative influence on the focus quality and sharpness. Thecoupling of the laser 16 is thereby advantageously improved. The laser16 which is used to excite the nanoparticles is a frequency-doubleddiode-pumped Nd:YAg-Laser (CNI Lasers Inc.), which is focused, with anoutput power of 2.5 W with a F-Theta lens (Jenoptik, focal length 100mm) behind a mirror scanner 17 (Cambridge Technologies, Pro Series 1)into the sample tubes 18 in the water bath 20 (focus diameterapproximately 20 μm). The mirror scanner 17 allows the focus to moveline by line through the sample tubes 18, as also already shown in FIG.3, and thus allows the whole PCR reaction volume to participate in theoptothermal amplification. For each sample tube 18, 680 lines with adistance of approximately 12 μm, with a line speed in the sample tubes18 of approximately 10 m/s, are covered with the focus. This correspondsto a cycle in the first sample tube 18. Subsequently all other sampletubes 18 are travelled over one after the other, so that each sampletube 18 has undergone a cycle. After a waiting period, which can beselected differently in each sample tube 18, the next cycle is started.This is repeated as often as needed with differences for each sampletube 18.

FIG. 6 shows data for five different sample tubes, which contain as astarting concentration of the original 103 in each case 0.1 fM. In thefirst sample tube a total of 200 cycles are carried out with a waitingtime of 3 s between the individual cycles, in the second sample tube 120cycles at 5 s, in the third sample tube 90 cycles at 6.6 s, in thefourth sample tube 60 cycles at 10 s and in the fifth sample tube 45cycles at 13.3 s. This is shown in FIG. 6b . The script below thediagrams indicates in each case the waiting time. The total durationfrom the first to the last cycle is 10 minutes in each of the fivesample tubes. This is shown in FIG. 6a . In order to determine the totalamplification through the optothermal amplification reaction, after theend of the amplification reaction 1 μl of the sample is removed fromeach sample tube and diluted in 99 μl water. From this dilution orthinning, 1 μl is introduced into an amplification reaction to bequantified (real-time PCR) in order to determine the concentration ofthe copies of the original there that were produced in the differentsample tubes by the optothermal amplification reaction. This dilutionserves for possibly inhibiting or interfering content substances fromthe optothermal amplification reaction being diluted too greatly, sothat they can no longer interfere in the subsequent quantifyingamplification reaction. The quantifying amplification reaction isperformed in a LightCycle II (Roche). Here, there is a cycle of 10 sdenaturing at 94° C., 10 s annealing at 62° C. and 10 s elongation at72° C. At the end of the 72° C. step, the measurement of thefluorescence is also carried out. Prior to the start of the first cycle,a once-only denaturing step takes place at 94° C. for 30 s. Besides 1 μlof the diluted copies of the original from the optothermal amplificationreaction, 10 μl reaction volume for the quantifying amplificationreaction contains 2 μl Apta Taq Mastermix 5× with MgCl₂ (obtained fromRoche), 2.8 μl water, 2 μl oligonucleotide 4 ID5 1 pM as dissolvedforward primer, 2 μl oligonucleotide 4 ID6 1 μM as a dissolved reverseprimer and 0.2 μl SYBRGreen 100× as intercalating colour dye in order tomake the PCR product detectable during the real-time PCR. An additionalstandard curve, which is determined with a diluting or thinning seriesof known concentrations of oligonucleotide 103 as original for thequantifying amplification reaction, allows the subsequent quantificationof the copies used into the quantifying amplification reaction. Thetotal amplification is thereby determined that was produced during theoptothermal amplification reaction in the different sample tubes. Thisis shown in FIG. 6d . It can clearly be seen here that the totalamplification, despite equal process time (in each case 10 minutes, seeFIG. 6a ), with increasing cycle duration (and thereby decreasing numberof cycles), greatly decreases. Assuming that over the wholeamplification reaction the amplification factor per cycle remainsconstant, the yield per cycle g can be calculated from Equation (2). Thethus determined g is shown in FIG. 6c . It can clearly be seen here thatg increases with increasing cycle duration. Despite the decreasing gwith decreasing cycle duration, the total amplification with the sameprocess duration increases with decreasing cycle duration.

FIG. 4 shows the idealized temperature profile of a conventional PCR(dotted line) with a cycle duration of t_(A), =15 s. A constant slope of5 K/s was assumed for the temperature flanks. In contrast, oneembodiment of the PCR method according to the invention, with a cycleduration t_(ch)=2 s, is shown with a constant slope of the temperatureflanks of 3000K/s, as can be achieved for example through opticalexcitation of nanoparticles according to the invention (solid line; forbetter legibility, the temperature profile was displaced by 1° C.downwards).

FIG. 5 shows the amplification factor N_(k)/N₀ as a function of the timefor different parameters. The pointed line shows the amplification of atypical conventional PCR with a cycle duration of t_(ch)=25 s and ayield per cycle of g_(h)=100%. The dotted line shows the amplificationin a preferred conversion according to the invention with

g_(t)=25%, x=4

$t_{c_{i}} = {\frac{t_{c_{h}}}{x} = {6,25\; s}}$

The solid line shows another preferred conversion according to theinvention with g_(i)=100%, x=2 and

$t_{c_{i}} = {\frac{t_{c_{h}}}{x} = {12,5\; s}}$

The features disclosed in the above description, the claims and thedrawings can be significant both individually as well as in anycombination for the realisation of the invention in its differentembodiments.

REFERENCE SYMBOL LIST

-   1 Nucleic acid-   3 Reaction volume-   3 First nanoparticles-   4 Oligonucleotide-   5 Primer sequence-   6 Spacer sequence-   7 Abasic modification-   8 Forward primer-   9 Nanoparticle-   10 Filling molecule-   11 DNA polymerase-   12 Sample-   13 Original; amplicon-   14 Complement-   15 Reverse primer-   16 Laser-   17 Mirror scanner-   18 Sample tube-   19 Glass cuvette-   20 Water bath

1. A method for amplifying nucleic acids by means of a polymerase chainreaction, wherein a cycle consisting of the steps denaturing, annealingand elongation is performed repeatedly.
 2. A method for amplifyingnucleic acids by means of a polymerase chain reaction, wherein a cycleconsisting of the steps denaturing, annealing and elongation isperformed repeatedly, wherein the yield (g) of specimens of a nucleicacid to be amplified, at the end of at least one of the passages of thecycle, is less than 80 percent of the specimens of the nucleic acidpresent at the start of this passage of the cycle, and that in at leastone of the passages of the cycle a duration of effect (t_(A)) is shorterthan one second.
 3. A method for amplifying nucleic acids by means of apolymerase chain reaction, wherein a cycle consisting of the stepsdenaturing, annealing and elongation is repeatedly performed, whereinthe cycle duration (t_(c)) with respect to the cycle duration of anotherwise identically performed reference polymerase chain reaction isreduced by the factor x, so that the yield (g) of specimens of a nucleicacid to be amplified. at the end of at least one of the passages of thecycle, with respect to the yield of an otherwise identically carried outreference PCR is reduced by the factor y, wherein x>0.9 y and g<80%. 4.A method for amplifying a nucleic acid by means of a polymerase chainreaction, wherein a cycle consisting of the steps denaturing, annealingand elongation is performed repeatedly, wherein the number (k) ofpassages of the cycle of the polymerase chain reaction is greater than45.
 5. A method for amplifying a nucleic acid by means of a polymerasechain reaction, wherein a cycle consisting of the steps denaturing,annealing and elongation is performed repeatedly, wherein, in at leastone of the passages of the cycle, a cycle duration t_(c) is shorter than20 s.
 6. The method of claim 1, wherein the yield (g) of nucleic acidsat the end of at least one of the passages of the cycle is less than 80%of the nucleic acids present at the start of this passage.
 7. The methodof claim 1, wherein in at least one of the passages of the cycle, aduration of effect (t_(A)) is less than 10 seconds.
 8. The method ofclaim 1, wherein the number (k) of the passages of the cycle of thepolymerase chain reaction is greater than
 45. 9. The method of claim 1,wherein the concentration of the amplicon to be amplified in the methodis less than 1 nM at the start of the method.
 10. The method of claim 1,wherein the cycle duration t_(c) is shorter than 20 seconds in at leastone of the passages of the cycle.
 11. The method of claim 1, whereinnanoparticles in a reaction volume transfer heat to their environmentthrough excitation.
 12. The method of claim 11, wherein a heating timein at least one of the passages of the cycle is shorter than 10 ms. 13.The method of claim 11, wherein a cooling time in at least one of thepassages of the cycle is shorter than 10 ms.
 14. The method of claim 11,wherein a power density, with which the nanoparticles are excited, ismore than 10 W/mm².
 15. The method of claim 11, wherein a power density,with which the nanoparticles are excited, is less than 20,000 kW/mm².16. The method of claim 11, wherein through the excitation of thenanoparticles the environment of the nanoparticles is locally heated.17. The method of claim 11, wherein the nanoparticles are excited by alaser.
 18. The method of claim 11, wherein the nanoparticles (9) areconjugated to oligonucleotides.
 19. The method of claim 11, wherein oneclass of conjugates of nanoparticles and oligonucleotides is conjugatedboth with forward primers and also reverse primers.
 20. The method ofclaim 18, wherein in the method counter-sequences are used, which cancombine with oligonucleotides that have detached from the nanoparticles,with which they were previously combined. 21-29. (canceled)